Ellen Vitetta - Publications

Affiliations: 
University of Texas Medical Center, Houston, TX, United States 
Area:
Immunology
Website:
http://www.utsouthwestern.edu/findfac/professional/0,2356,17609,00.html

379 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 BitMansour A, Pop LM, Vitetta ES. The Role of Regulatory B Cell-Like Malignant Cells and Treg Cells in the Mouse Model of BCL1 Tumor Dormancy. Plos One. 11: e0167618. PMID 27959896 DOI: 10.1371/journal.pone.0167618  0.36
2016 Takeshima T, Pop LM, Laine A, Iyengar P, Vitetta ES, Hannan R. Key role for neutrophils in radiation-induced antitumor immune responses: Potentiation with G-CSF. Proceedings of the National Academy of Sciences of the United States of America. PMID 27651484 DOI: 10.1073/Pnas.1613187113  0.36
2016 Case A, Desmond A, Lopes D, Dye K, Mapes K, Ruback S, Pop I, Kim JK, Chakravarty P, Smallshaw JE, Pop LM, Vitetta ES. The Immunogenicity of Peptoid-Protein Conjugates. Journal of Vaccines & Vaccination. 7. PMID 27595050 DOI: 10.4172/2157-7560.1000329  0.36
2015 Roy CJ, Brey RN, Mantis NJ, Mapes K, Pop IV, Pop LM, Ruback S, Killeen SZ, Doyle-Meyers L, Vinet-Oliphant HS, Didier PJ, Vitetta ES. Thermostable ricin vaccine protects rhesus macaques against aerosolized ricin: Epitope-specific neutralizing antibodies correlate with protection. Proceedings of the National Academy of Sciences of the United States of America. 112: 3782-7. PMID 25775591 DOI: 10.1073/pnas.1502585112  1
2014 Pop LM, Barman S, Shao C, Poe JC, Venturi GM, Shelton JM, Pop IV, Gerber DE, Girard L, Liu XY, Behrens C, Rodriguez-Canales J, Liu H, Wistuba II, Richardson JA, ... ... Vitetta ES, et al. A reevaluation of CD22 expression in human lung cancer. Cancer Research. 74: 263-71. PMID 24395821 DOI: 10.1158/0008-5472.CAN-13-1436  1
2013 Sturge CR, Benson A, Raetz M, Wilhelm CL, Mirpuri J, Vitetta ES, Yarovinsky F. TLR-independent neutrophil-derived IFN-γ is important for host resistance to intracellular pathogens. Proceedings of the National Academy of Sciences of the United States of America. 110: 10711-6. PMID 23754402 DOI: 10.1073/pnas.1307868110  1
2013 Howard M, Farrar J, Hilfiker M, Johnson B, Takatsu K, Hamaoka T, Paul WE. Pillars article: Identification of a T cell-derived B cell growth factor distinct from interleukin 2. J. Exp. Med. 1982. 155: 914-923. Journal of Immunology (Baltimore, Md. : 1950). 190: 864-73. PMID 23335802 DOI: 10.4049/jimmunol.1203368  1
2013 Isakson PC, Puré E, Vitetta ES, Krammer PH. Pillars article: T cell-derived B cell differentiation factor(s). Effect on the isotype switch of murine B cells. J. Exp. Med. 1982. 155: 734-748. Journal of Immunology (Baltimore, Md. : 1950). 190: 849-63. PMID 23335801 DOI: 10.4049/jimmunol.1203368  0.56
2012 Vitetta ES, Smallshaw JE, Schindler J. Pilot phase IB clinical trial of an alhydrogel-adsorbed recombinant ricin vaccine. Clinical and Vaccine Immunology : Cvi. 19: 1697-9. PMID 22914366 DOI: 10.1128/CVI.00381-12  1
2012 Wachsmann MB, Pop LM, Vitetta ES. Pancreatic ductal adenocarcinoma: a review of immunologic aspects. Journal of Investigative Medicine : the Official Publication of the American Federation For Clinical Research. 60: 643-63. PMID 22406516 DOI: 10.2310/JIM.0b013e31824a4d79  1
2012 Liu XY, Pop LM, Schindler J, Vitetta ES. Immunotoxins constructed with chimeric, short-lived anti-CD22 monoclonal antibodies induce less vascular leak without loss of cytotoxicity. Mabs. 4: 57-68. PMID 22327430 DOI: 10.4161/mabs.4.1.18348  1
2012 Smallshaw JE, Vitetta ES. Ricin vaccine development. Current Topics in Microbiology and Immunology. 357: 259-72. PMID 21805396 DOI: 10.1007/82_2011_156  1
2012 Ma S, Richardson J, Bitmansour A, Solberg T, Pidikiti R, Song K, Stojadinovic S, Vitetta E, Meyer J. Depletion of Regulatory T Cells Does Not Influence the Inflammatory Response Induced by High-dose Irradiation International Journal of Radiation Oncology*Biology*Physics. 84: S689-S690. DOI: 10.1016/J.Ijrobp.2012.07.1842  0.56
2011 Pincus SH, Smallshaw JE, Song K, Berry J, Vitetta ES. Passive and active vaccination strategies to prevent ricin poisoning. Toxins. 3: 1163-84. PMID 22069761 DOI: 10.3390/toxins3091163  1
2011 Tsai LK, Pop LM, Liu X, Vitetta ES. A comparison of the anti-tumor effects of a chimeric versus murine anti-CD19 immunotoxins on human B cell lymphoma and Pre-B acute lymphoblastic leukemia cell lines. Toxins. 3: 409-19. PMID 22069716 DOI: 10.3390/toxins3040409  1
2011 Legler PM, Brey RN, Smallshaw JE, Vitetta ES, Millard CB. Structure of RiVax: a recombinant ricin vaccine. Acta Crystallographica. Section D, Biological Crystallography. 67: 826-30. PMID 21904036 DOI: 10.1107/S0907444911026771  1
2011 Schindler J, Gajavelli S, Ravandi F, Shen Y, Parekh S, Braunchweig I, Barta S, Ghetie V, Vitetta E, Verma A. A phase I study of a combination of anti-CD19 and anti-CD22 immunotoxins (Combotox) in adult patients with refractory B-lineage acute lymphoblastic leukaemia. British Journal of Haematology. 154: 471-6. PMID 21732928 DOI: 10.1111/j.1365-2141.2011.08762.x  1
2011 Marches R, Mikoryak C, Wang RH, Pantano P, Draper RK, Vitetta ES. The importance of cellular internalization of antibody-targeted carbon nanotubes in the photothermal ablation of breast cancer cells. Nanotechnology. 22: 095101. PMID 21258147 DOI: 10.1088/0957-4484/22/9/095101  1
2011 Liu XY, Pop LM, Tsai L, Pop IV, Vitetta ES. Chimeric, divalent and tetravalent anti-CD19 monoclonal antibodies with potent in vitro and in vivo antitumor activity against human B-cell lymphoma and pre-B acute lymphoblastic leukemia cell lines. International Journal of Cancer. Journal International Du Cancer. 129: 497-506. PMID 20878959 DOI: 10.1002/ijc.25695  1
2010 Marconescu PS, Smallshaw JE, Pop LM, Ruback SL, Vitetta ES. Intradermal administration of RiVax protects mice from mucosal and systemic ricin intoxication. Vaccine. 28: 5315-22. PMID 20562013 DOI: 10.1016/j.vaccine.2010.05.045  1
2010 Smallshaw JE, Vitetta ES. A lyophilized formulation of RiVax, a recombinant ricin subunit vaccine, retains immunogenicity. Vaccine. 28: 2428-35. PMID 20074685 DOI: 10.1016/j.vaccine.2009.12.081  1
2009 Herrera L, Bostrom B, Gore L, Sandler E, Lew G, Schlegel PG, Aquino V, Ghetie V, Vitetta ES, Schindler J. A phase 1 study of Combotox in pediatric patients with refractory B-lineage acute lymphoblastic leukemia. Journal of Pediatric Hematology/Oncology. 31: 936-41. PMID 19875969 DOI: 10.1097/MPH.0b013e3181bdf211  1
2009 Pop IV, Pop LM, Ghetie MA, Vitetta ES. Targeting mammalian target of rapamycin to both downregulate and disable the P-glycoprotein pump in multidrug-resistant B-cell lymphoma cell lines. Leukemia & Lymphoma. 50: 1155-62. PMID 19557637 DOI: 10.1080/10428190903046722  1
2009 Marches R, Chakravarty P, Musselman IH, Bajaj P, Azad RN, Pantano P, Draper RK, Vitetta ES. Specific thermal ablation of tumor cells using single-walled carbon nanotubes targeted by covalently-coupled monoclonal antibodies. International Journal of Cancer. Journal International Du Cancer. 125: 2970-7. PMID 19536775 DOI: 10.1002/Ijc.24659  1
2008 Brooks KJ, Coleman EJ, Vitetta ES. The antitumor activity of an anti-CD54 antibody in SCID mice xenografted with human breast, prostate, non-small cell lung, and pancreatic tumor cell lines. International Journal of Cancer. Journal International Du Cancer. 123: 2438-45. PMID 18752248 DOI: 10.1002/ijc.23793  1
2008 Chakravarty P, Marches R, Zimmerman NS, Swafford AD, Bajaj P, Musselman IH, Pantano P, Draper RK, Vitetta ES. Thermal ablation of tumor cells with antibody-functionalized single-walled carbon nanotubes. Proceedings of the National Academy of Sciences of the United States of America. 105: 8697-702. PMID 18559847 DOI: 10.1073/Pnas.0803557105  1
2008 Powell DJ, Attia P, Ghetie V, Schindler J, Vitetta ES, Rosenberg SA. Partial reduction of human FOXP3+ CD4 T cells in vivo after CD25-directed recombinant immunotoxin administration. Journal of Immunotherapy (Hagerstown, Md. : 1997). 31: 189-98. PMID 18481388 DOI: 10.1097/CJI.0b013e31815dc0e8  1
2008 Liu XY, Pop LM, Vitetta ES. Engineering therapeutic monoclonal antibodies. Immunological Reviews. 222: 9-27. PMID 18363992 DOI: 10.1111/j.1600-065X.2008.00601.x  1
2008 Pop I, Pop L, Vitetta ES, Ghetie MA. Generation of multidrug resistant lymphoma cell lines stably expressing P-glycoprotein. Oncology Reports. 19: 889-95. PMID 18357372  1
2007 Smallshaw JE, Richardson JA, Vitetta ES. RiVax, a recombinant ricin subunit vaccine, protects mice against ricin delivered by gavage or aerosol. Vaccine. 25: 7459-69. PMID 17875350 DOI: 10.1016/j.vaccine.2007.08.018  1
2007 Mielke S, Rezvani K, Savani BN, Nunes R, Yong AS, Schindler J, Kurlander R, Ghetie V, Read EJ, Solomon SR, Vitetta ES, Barrett AJ. Reconstitution of FOXP3+ regulatory T cells (Tregs) after CD25-depleted allotransplantation in elderly patients and association with acute graft-versus-host disease. Blood. 110: 1689-97. PMID 17478639 DOI: 10.1182/blood-2007-03-079160  1
2007 Rabinovsky R, Uhr JW, Vitetta ES, Yefenof E. Cancer dormancy: lessons from a B cell lymphoma and adenocarcinoma of the prostate. Advances in Cancer Research. 97: 189-202. PMID 17419946 DOI: 10.1016/S0065-230X(06)97008-0  1
2006 Herrera L, Stanciu-Herrera C, Morgan C, Ghetie V, Vitetta ES. Anti-CD19 immunotoxin enhances the activity of chemotherapy in severe combined immunodeficient mice with human pre-B acute lymphoblastic leukemia. Leukemia & Lymphoma. 47: 2380-7. PMID 17107913 DOI: 10.1080/10428190600821989  1
2006 Ghetie MA, Crank M, Kufert S, Pop I, Vitetta E. Rituximab but not other anti-CD20 antibodies reverses multidrug resistance in 2 B lymphoma cell lines, blocks the activity of P-glycoprotein (P-gp), and induces P-gp to translocate out of lipid rafts. Journal of Immunotherapy (Hagerstown, Md. : 1997). 29: 536-44. PMID 16971809 DOI: 10.1097/01.cji.0000211307.05869.6c  1
2006 Coleman EJ, Brooks KJ, Smallshaw JE, Vitetta ES. The Fc portion of UV3, an anti-CD54 monoclonal antibody, is critical for its antitumor activity in SCID mice with human multiple myeloma or lymphoma cell lines. Journal of Immunotherapy (Hagerstown, Md. : 1997). 29: 489-98. PMID 16971805 DOI: 10.1097/01.cji.0000210079.52554.c3  1
2006 Vitetta ES, Ghetie VF. Immunology. Considering therapeutic antibodies. Science (New York, N.Y.). 313: 308-9. PMID 16857927 DOI: 10.1126/science.1130482  1
2006 Amrolia PJ, Muccioli-Casadei G, Huls H, Adams S, Durett A, Gee A, Yvon E, Weiss H, Cobbold M, Gaspar HB, Rooney C, Kuehnle I, Ghetie V, Schindler J, Krance R, ... ... Vitetta E, et al. Adoptive immunotherapy with allodepleted donor T-cells improves immune reconstitution after haploidentical stem cell transplantation. Blood. 108: 1797-808. PMID 16741253 DOI: 10.1182/blood-2006-02-001909  1
2006 Liu XY, Pop LM, Roopenian DC, Ghetie V, Vitetta ES, Smallshaw JE. Generation and characterization of a novel tetravalent anti-CD22 antibody with improved antitumor activity and pharmacokinetics. International Immunopharmacology. 6: 791-9. PMID 16546710 DOI: 10.1016/J.Intimp.2005.11.022  1
2006 Vitetta ES, Smallshaw JE, Coleman E, Jafri H, Foster C, Munford R, Schindler J. A pilot clinical trial of a recombinant ricin vaccine in normal humans. Proceedings of the National Academy of Sciences of the United States of America. 103: 2268-73. PMID 16461456 DOI: 10.1073/pnas.0510893103  1
2006 Vaclavkova P, Cao Y, Wu LK, Michalek J, Vitetta ES. A comparison of an anti-CD25 immunotoxin, Ontak and anti-CD25 microbeads for their ability to deplete alloreactive T cells in vitro. Bone Marrow Transplantation. 37: 559-67. PMID 16444279 DOI: 10.1038/sj.bmt.1705286  1
2006 Wang S, Coleman EJ, Pop LM, Brooks KJ, Vitetta ES, Niederkorn JY. Effect of an anti-CD54 (ICAM-1) monoclonal antibody (UV3) on the growth of human uveal melanoma cells transplanted heterotopically and orthotopically in SCID mice. International Journal of Cancer. Journal International Du Cancer. 118: 932-41. PMID 16152588 DOI: 10.1002/ijc.21289  1
2005 Vallera DA, Brechbiel MW, Burns LJ, Panoskaltsis-Mortari A, Dusenbery KE, Clohisy DR, Vitetta ES. Radioimmunotherapy of CD22-expressing Daudi tumors in nude mice with a 90Y-labeled anti-CD22 monoclonal antibody. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 7920-8. PMID 16278417 DOI: 10.1158/1078-0432.CCR-05-0725  1
2005 Pop LM, Smallshaw JE, Tucker TF, Stevenson FK, Vitetta ES. Failure of vaccination with idiotypic protein or DNA, (+/-IL-2), the depletion of regulatory T cells, or the blockade of CTLA-4 to prolong dormancy in mice with BCL1 lymphoma. Journal of Immunotherapy (Hagerstown, Md. : 1997). 28: 525-34. PMID 16224269  1
2005 Amrolia PJ, Mucioli-Casadei G, Huls H, Heslop HE, Schindler J, Veys P, Vitetta ES, Brenner MK. Add-back of allodepleted donor T cells to improve immune reconstitution after haplo-identical stem cell transplantation. Cytotherapy. 7: 116-25. PMID 16047416 DOI: 10.1080/14653240510018181  1
2005 Savelyeva N, King CA, Vitetta ES, Stevenson FK. Inhibition of a vaccine-induced anti-tumor B cell response by soluble protein antigen in the absence of continuing T cell help. Proceedings of the National Academy of Sciences of the United States of America. 102: 10987-92. PMID 16037207 DOI: 10.1073/pnas.0505108102  1
2005 Savellano MD, Pogue BW, Hoopes PJ, Vitetta ES, Paulsen KD. Multiepitope HER2 targeting enhances photoimmunotherapy of HER2-overexpressing cancer cells with pyropheophorbide-a immunoconjugates. Cancer Research. 65: 6371-9. PMID 16024640 DOI: 10.1158/0008-5472.Can-05-0426  1
2005 Smallshaw JE, Richardson JA, Pincus S, Schindler J, Vitetta ES. Preclinical toxicity and efficacy testing of RiVax, a recombinant protein vaccine against ricin. Vaccine. 23: 4775-84. PMID 15961194 DOI: 10.1016/j.vaccine.2005.04.037  1
2005 Pop LM, Liu X, Ghetie V, Vitetta ES. The generation of immunotoxins using chimeric anti-CD22 antibodies containing mutations which alter their serum half-life. International Immunopharmacology. 5: 1279-90. PMID 15914332 DOI: 10.1016/j.intimp.2005.03.013  1
2005 Solomon SR, Mielke S, Savani BN, Montero A, Wisch L, Childs R, Hensel N, Schindler J, Ghetie V, Leitman SF, Mai T, Carter CS, Kurlander R, Read EJ, Vitetta ES, et al. Selective depletion of alloreactive donor lymphocytes: a novel method to reduce the severity of graft-versus-host disease in older patients undergoing matched sibling donor stem cell transplantation. Blood. 106: 1123-9. PMID 15817673 DOI: 10.1182/blood-2005-01-0393  1
2004 Smallshaw JE, Coleman E, Spiridon C, Vitetta ES. The generation and anti-myeloma activity of a chimeric anti-CD54 antibody, cUV3. Journal of Immunotherapy (Hagerstown, Md. : 1997). 27: 419-24. PMID 15534485  1
2004 Martin PJ, Pei J, Gooley T, Anasetti C, Appelbaum FR, Deeg J, Hansen JA, Nash RA, Petersdorf EW, Storb R, Ghetie V, Schindler J, Vitetta ES. Evaluation of a CD25-specific immunotoxin for prevention of graft-versus-host disease after unrelated marrow transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 10: 552-60. PMID 15282533 DOI: 10.1016/j.bbmt.2004.04.002  1
2004 Saavedra-Lozano J, McCoig CC, Cao Y, Vitetta ES, Ramilo O. Zidovudine, lamivudine, and abacavir have different effects on resting cells infected with human immunodeficiency virus in vitro. Antimicrobial Agents and Chemotherapy. 48: 2825-30. PMID 15273087 DOI: 10.1128/AAC.48.8.2825-2830.2004  1
2004 Meng S, Tripathy D, Shete S, Ashfaq R, Haley B, Perkins S, Beitsch P, Khan A, Euhus D, Osborne C, Frenkel E, Hoover S, Leitch M, Clifford E, Vitetta E, et al. HER-2 gene amplification can be acquired as breast cancer progresses. Proceedings of the National Academy of Sciences of the United States of America. 101: 9393-8. PMID 15194824 DOI: 10.1073/pnas.0402993101  1
2004 Spiridon CI, Guinn S, Vitetta ES. A comparison of the in vitro and in vivo activities of IgG and F(ab')2 fragments of a mixture of three monoclonal anti-Her-2 antibodies. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 3542-51. PMID 15161714 DOI: 10.1158/1078-0432.CCR-03-0549  1
2004 Vallera DA, Elson M, Brechbiel MW, Dusenbery KE, Burns LJ, Jaszcz WB, Ramsay NK, Panoskaltsis-Mortar A, Kuroki DW, Wagner JE, Vitetta ES, Kersey JH. Radiotherapy of CD19 expressing Daudi tumors in nude mice with Yttrium-90-labeled anti-CD19 antibody. Cancer Biotherapy & Radiopharmaceuticals. 19: 11-23. PMID 15068607 DOI: 10.1089/108497804773391630  1
2004 Ghetie MA, Marches R, Kufert S, Vitetta ES. An anti-CD19 antibody inhibits the interaction between P-glycoprotein (P-gp) and CD19, causes P-gp to translocate out of lipid rafts, and chemosensitizes a multidrug-resistant (MDR) lymphoma cell line. Blood. 104: 178-83. PMID 15001473 DOI: 10.1182/blood-2003-12-4255  1
2004 Saavedra-Lozano J, Cao Y, Callison J, Sarode R, Sodora D, Edgar J, Hatfield J, Picker L, Peterson D, Ramilo O, Vitetta ES. An anti-CD45RO immunotoxin kills HIV-latently infected cells from individuals on HAART with little effect on CD8 memory. Proceedings of the National Academy of Sciences of the United States of America. 101: 2494-9. PMID 14983037 DOI: 10.1073/Pnas.0308381100  1
2004 Meng R, Smallshaw JE, Pop LM, Yen M, Liu X, Le L, Ghetie MA, Vitetta ES, Ghetie V. The evaluation of recombinant, chimeric, tetravalent antihuman CD22 antibodies. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 1274-81. PMID 14977825 DOI: 10.1158/1078-0432.CCR-1154-03  1
2003 Michálek J, Collins RH, Vitetta ES. Clinical-scale selective depletion of alloreactive T cells using an anti-CD25 immunotoxin. Neoplasma. 50: 296-9. PMID 12937844  1
2003 Schnell R, Borchmann P, Staak JO, Schindler J, Ghetie V, Vitetta ES, Engert A. Clinical evaluation of ricin A-chain immunotoxins in patients with Hodgkin's lymphoma. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 14: 729-36. PMID 12702527 DOI: 10.1093/annonc/mdg209  1
2003 Smallshaw JE, Ghetie V, Rizo J, Fulmer JR, Trahan LL, Ghetie MA, Vitetta ES. Genetic engineering of an immunotoxin to eliminate pulmonary vascular leak in mice. Nature Biotechnology. 21: 387-91. PMID 12627168 DOI: 10.1038/nbt800  1
2003 Herrera L, Yarbrough S, Ghetie V, Aquino DB, Vitetta ES. Treatment of SCID/human B cell precursor ALL with anti-CD19 and anti-CD22 immunotoxins. Leukemia. 17: 334-8. PMID 12592332 DOI: 10.1038/sj.leu.2402790  1
2003 Michalek J, Collins RH, Durrani HP, Vaclavkova P, Ruff LE, Douek DC, Vitetta ES. Definitive separation of graft-versus-leukemia- and graft-versus-host-specific CD4+ T cells by virtue of their receptor beta loci sequences. Proceedings of the National Academy of Sciences of the United States of America. 100: 1180-4. PMID 12531922 DOI: 10.1073/pnas.0337543100  1
2003 Michálek J, Collins RH, Vitetta ES. Prevention of graft-versus-host disease in patients undergoing allogeneic hematopoietic stem cell transplantation using an anti-CD25 immunotoxin | Prevence reakce štěpu proti hostiteli u pacientů podstupujících alogenní transplantaci hematopoetických kmenových buněk pomocí anti-CD25 imunotoxinu Klinicka Onkologie. 16: 134-137.  1
2002 Solomon SR, Tran T, Carter CS, Donnelly S, Hensel N, Schindler J, Bahceci E, Ghetie V, Michálek J, Mavroudis D, Read EJ, Vitetta ES, Barrett AJ. Optimized clinical-scale culture conditions for ex vivo selective depletion of host-reactive donor lymphocytes: a strategy for GvHD prophylaxis in allogeneic PBSC transplantation. Cytotherapy. 4: 395-406. PMID 12473206 DOI: 10.1080/146532402320775982  1
2002 André-Schmutz I, Le Deist F, Hacein-Bey S, Hamel Y, Vitetta E, Schindler J, Fischer A, Cavazzana-Calvo M. Donor T lymphocyte infusion following ex vivo depletion of donor anti-host reactivity by a specific anti-interleukin-2 receptor P55 chain immunotoxin. Transplantation Proceedings. 34: 2927-8. PMID 12431660 DOI: 10.1016/S0041-1345(02)03491-7  1
2002 Hayes DF, Walker TM, Singh B, Vitetta ES, Uhr JW, Gross S, Rao C, Doyle GV, Terstappen LW. Monitoring expression of HER-2 on circulating epithelial cells in patients with advanced breast cancer. International Journal of Oncology. 21: 1111-7. PMID 12370762 DOI: 10.3892/IJO.21.5.1111  1
2002 Smallshaw JE, Firan A, Fulmer JR, Ruback SL, Ghetie V, Vitetta ES. A novel recombinant vaccine which protects mice against ricin intoxication. Vaccine. 20: 3422-7. PMID 12213413 DOI: 10.1016/S0264-410X(02)00312-2  1
2002 André-Schmutz I, Le Deist F, Hacein-Bey-Abina S, Vitetta E, Schindler J, Chedeville G, Vilmer E, Fischer A, Cavazzana-Calvo M. Immune reconstitution without graft-versus-host disease after haemopoietic stem-cell transplantation: a phase 1/2 study. Lancet. 360: 130-7. PMID 12126823 DOI: 10.1016/S0140-6736(02)09413-8  1
2002 Schnell R, Staak O, Borchmann P, Schwartz C, Matthey B, Hansen H, Schindler J, Ghetie V, Vitetta ES, Diehl V, Engert A. A Phase I study with an anti-CD30 ricin A-chain immunotoxin (Ki-4.dgA) in patients with refractory CD30+ Hodgkin's and non-Hodgkin's lymphoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 8: 1779-86. PMID 12060617  1
2002 Spiridon CI, Ghetie MA, Uhr J, Marches R, Li JL, Shen GL, Vitetta ES. Targeting multiple Her-2 epitopes with monoclonal antibodies results in improved antigrowth activity of a human breast cancer cell line in vitro and in vivo. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 8: 1720-30. PMID 12060609  1
2002 Saavedra-Lozano J, McCoig C, Xu J, Cao Y, Keiser P, Ghetie V, Siliciano RF, Siliciano JD, Picker LJ, Ramilo O, Vitetta ES. An anti-CD45RO immunotoxin kills latently infected human immunodeficiency virus (HIV) CD4 T cells in the blood of HIV-positive persons. The Journal of Infectious Diseases. 185: 306-14. PMID 11807712 DOI: 10.1086/338565  1
2001 Ghetie V, Vitetta ES. Chemical construction of immunotoxins. Molecular Biotechnology. 18: 251-68. PMID 11503519 DOI: 10.1385/MB:18:3:251  1
2001 Alwayn IP, Xu Y, Basker M, Wu C, Buhler L, Lambrigts D, Treter S, Harper D, Kitamura H, Vitetta ES, Abraham S, Awwad M, White-Scharf ME, Sachs DH, Thall A, et al. Effects of specific anti-B and/or anti-plasma cell immunotherapy on antibody production in baboons: depletion of CD20- and CD22-positive B cells does not result in significantly decreased production of anti-alphaGal antibody. Xenotransplantation. 8: 157-71. PMID 11472623 DOI: 10.1034/j.1399-3089.2001.008003157.x  1
2001 Marches R, Vitetta ES, Uhr JW. A role for intracellular pH in membrane IgM-mediated cell death of human B lymphomas. Proceedings of the National Academy of Sciences of the United States of America. 98: 3434-9. PMID 11248096 DOI: 10.1073/pnas.061028998  1
2001 Schindler J, Sausville E, Messmann R, Uhr JW, Vitetta ES. The toxicity of deglycosylated ricin A chain-containing immunotoxins in patients with non-Hodgkin's lymphoma is exacerbated by prior radiotherapy: a retrospective analysis of patients in five clinical trials. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 7: 255-8. PMID 11234876  1
2001 Ghetie MA, Bright H, Vitetta ES. Homodimers but not monomers of Rituxan (chimeric anti-CD20) induce apoptosis in human B-lymphoma cells and synergize with a chemotherapeutic agent and an immunotoxin. Blood. 97: 1392-8. PMID 11222385 DOI: 10.1182/blood.V97.5.1392  1
2000 Clinchy B, Gazdar A, Rabinovsky R, Yefenof E, Gordon B, Vitetta ES. The growth and metastasis of human, HER-2/neu-overexpressing tumor cell lines in male SCID mice. Breast Cancer Research and Treatment. 61: 217-28. PMID 10965998 DOI: 10.1023/A:1006494001861  1
2000 Xu Y, Ryan D, Wu C, Kiessling L, Xu J, Morgan P, Vitetta E, White-Scharf ME, Thall AD. In vitro and in vivo inhibition of anti-gal secreting cells. Transplantation Proceedings. 32: 856. PMID 10936242 DOI: 10.1016/S0041-1345(00)01008-3  1
2000 Baluna R, Coleman E, Jones C, Ghetie V, Vitetta ES. The effect of a monoclonal antibody coupled to ricin A chain-derived peptides on endothelial cells in vitro: insights into toxin-mediated vascular damage. Experimental Cell Research. 258: 417-24. PMID 10896793 DOI: 10.1006/excr.2000.4954  1
2000 Vitetta ES. Immunotoxins and vascular leak syndrome. Cancer Journal (Sudbury, Mass.). 6: S218-24. PMID 10874491  1
2000 Herrera L, Farah RA, Pellegrini VA, Aquino DB, Sandler ES, Buchanan GR, Vitetta ES. Immunotoxins against CD19 and CD22 are effective in killing precursor-B acute lymphoblastic leukemia cells in vitro. Leukemia. 14: 853-8. PMID 10803517  1
2000 Messmann RA, Vitetta ES, Headlee D, Senderowicz AM, Figg WD, Schindler J, Michiel DF, Creekmore S, Steinberg SM, Kohler D, Jaffe ES, Stetler-Stevenson M, Chen H, Ghetie V, Sausville EA. A phase I study of combination therapy with immunotoxins IgG-HD37-deglycosylated ricin A chain (dgA) and IgG-RFB4-dgA (Combotox) in patients with refractory CD19(+), CD22(+) B cell lymphoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 6: 1302-13. PMID 10778955  1
2000 Wei BR, Ghetie MA, Vitetta ES. The combined use of an immunotoxin and a radioimmunoconjugate to treat disseminated human B-cell lymphoma in immunodeficient mice. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 6: 631-42. PMID 10690549  1
2000 Schnell R, Vitetta E, Schindler J, Borchmann P, Barth S, Ghetie V, Hell K, Drillich S, Diehl V, Engert A. Treatment of refractory Hodgkin's lymphoma patients with an anti-CD25 ricin A-chain immunotoxin. Leukemia. 14: 129-35. PMID 10637488 DOI: 10.1038/Sj.Leu.2401626  1
2000 Schnell R, Staak JO, Vitetta E, Schindler J, Borchmann P, Earth S, Diehl V, Engert A. IS there a clinical value for ricin a-chain immunotoxins in hodgkins lymphoma Blood. 96: 248b.  1
2000 Michalek J, Collins RH, Vitetta ES. The effect of different enhancers on the ability of an anti-CD2S ricin a chain immunotoxin to deplete cells which are activated in an MLR Blood. 96: 312b.  1
1999 Ghetie MA, Ghetie V, Vitetta ES. Anti-CD19 antibodies inhibit the function of the P-gp pump in multidrug-resistant B lymphoma cells. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 5: 3920-7. PMID 10632321  1
1999 McCoig C, Van Dyke G, Chou CS, Picker LJ, Ramilo O, Vitetta ES. An anti-CD45RO immunotoxin eliminates T cells latently infected with HIV-1 in vitro. Proceedings of the National Academy of Sciences of the United States of America. 96: 11482-5. PMID 10500202 DOI: 10.1073/pnas.96.20.11482  1
1999 Baluna R, Rizo J, Gordon BE, Ghetie V, Vitetta ES. Evidence for a structural motif in toxins and interleukin-2 that may be responsible for binding to endothelial cells and initiating vascular leak syndrome. Proceedings of the National Academy of Sciences of the United States of America. 96: 3957-62. PMID 10097145 DOI: 10.1073/pnas.96.7.3957  1
1999 Baluna R, Vitetta ES. An in vivo model to study immunotoxin-induced vascular leak in human tissue. Journal of Immunotherapy (Hagerstown, Md. : 1997). 22: 41-7. PMID 9924698 DOI: 10.1097/00002371-199901000-00006  1
1998 Clinchy B, Vitetta ES. The use of an anti-CD3 immunotoxin to prevent the development of lymphoproliferative disease in SCID/PBL mice. Journal of Immunological Methods. 218: 141-53. PMID 9819131 DOI: 10.1016/S0022-1759(98)00123-9  1
1998 Farah RA, Clinchy B, Herrera L, Vitetta ES. The development of monoclonal antibodies for the therapy of cancer. Critical Reviews in Eukaryotic Gene Expression. 8: 321-56. PMID 9807699  1
1998 Bascon JU, Vitetta E. Vascular leak syndrome: A troublesome side effect of immunotherapy (multiple letters) Immunopharmacology. 39: 255-257. PMID 9754911 DOI: 10.1016/S0162-3109(98)00027-7  1
1998 Schnell R, Vitetta E, Schindler J, Barth S, Winkler U, Borchmann P, Hansmann ML, Diehl V, Ghetie V, Engert A. Clinical trials with an anti-CD25 ricin A-chain experimental and immunotoxin (RFT5-SMPT-dgA) in Hodgkin's lymphoma. Leukemia & Lymphoma. 30: 525-37. PMID 9711915 DOI: 10.3109/10428199809057565  1
1998 Engert A, Sausville EA, Vitetta E. The emerging role of ricin A-chain immunotoxins in leukemia and lymphoma. Current Topics in Microbiology and Immunology. 234: 13-33. PMID 9670610  1
1998 Gelber EE, Vitetta ES. Effect of immunosuppressive agents on the immunogenicity and efficacy of an immunotoxin in mice. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 4: 1297-304. PMID 9607590  1
1997 Baluna R, Vitetta ES. Vascular leak syndrome: a side effect of immunotherapy. Immunopharmacology. 37: 117-32. PMID 9403331 DOI: 10.1016/S0162-3109(97)00041-6  1
1997 Ghetie MA, Ghetie V, Vitetta ES. Immunotoxins for the treatment of B-cell lymphomas. Molecular Medicine (Cambridge, Mass.). 3: 420-7. PMID 9260154  1
1997 Epzsteyn S, Vitetta ES, Yefenof E. Prophylactic intervention in RadLV-induced lymphomagenesis with an anti-IL-4 monoclonal antibody. Journal of Immunotherapy (Hagerstown, Md. : 1997). 20: 287-91. PMID 9220318 DOI: 10.1097/00002371-199707000-00005  1
1997 Ghetie MA, Podar EM, Ilgen A, Gordon BE, Uhr JW, Vitetta ES. Homodimerization of tumor-reactive monoclonal antibodies markedly increases their ability to induce growth arrest or apoptosis of tumor cells. Proceedings of the National Academy of Sciences of the United States of America. 94: 7509-14. PMID 9207122 DOI: 10.1073/pnas.94.14.7509  1
1997 Vitetta ES, Tucker TF, Racila E, Huang YW, Marches R, Lane N, Scheuermann RH, Street NE, Watanabe T, Uhr JW. Tumor dormancy and cell signaling. V. Regrowth of the BCL1 tumor after dormancy is established. Blood. 89: 4425-36. PMID 9192767 DOI: 10.1182/Blood.V89.12.4425  1
1997 Senderowicz AM, Vitetta E, Headlee D, Ghetie V, Uhr JW, Figg WD, Lush RM, Stetler-Stevenson M, Kershaw G, Kingma DW, Jaffe ES, Sausville EA. Complete sustained response of a refractory, post-transplantation, large B-cell lymphoma to an anti-CD22 immunotoxin. Annals of Internal Medicine. 126: 882-5. PMID 9163289 DOI: 10.7326/0003-4819-126-11-199706010-00005  1
1997 Huang YW, Baluna R, Vitetta ES. Adhesion molecules as targets for cancer therapy. Histology and Histopathology. 12: 467-77. PMID 9151136  1
1997 Uhr JW, Scheuermann RH, Street NE, Vitetta ES. Cancer dormancy: opportunities for new therapeutic approaches. Nature Medicine. 3: 505-9. PMID 9142117 DOI: 10.1038/Nm0597-505  1
1997 Chou CS, Ramilo O, Vitetta ES. Highly purified CD25- resting T cells cannot be infected de novo with HIV-1. Proceedings of the National Academy of Sciences of the United States of America. 94: 1361-5. PMID 9037058 DOI: 10.1073/pnas.94.4.1361  1
1997 Engert A, Diehl V, Schnell R, Radszuhn A, Hatwig MT, Drillich S, Schön G, Bohlen H, Tesch H, Hansmann ML, Barth S, Schindler J, Ghetie V, Uhr J, Vitetta E. A phase-I study of an anti-CD25 ricin A-chain immunotoxin (RFT5-SMPT-dgA) in patients with refractory Hodgkin's lymphoma. Blood. 89: 403-10. PMID 9002941 DOI: 10.1182/Blood.V89.2.403  1
1996 Baluna R, Sausville EA, Stone MJ, Stetler-Stevenson MA, Uhr JW, Vitetta ES. Decreases in levels of serum fibronectin predict the severity of vascular leak syndrome in patients treated with ricin A chain-containing immunotoxins. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 2: 1705-12. PMID 9816120  1
1996 Baluna R, Ghetie V, Oppenheimer-Marks N, Vitetta ES. Fibronectin inhibits the cytotoxic effect of ricin A chain on endothelial cells. International Journal of Immunopharmacology. 18: 355-61. PMID 9024936 DOI: 10.1016/S0192-0561(96)00043-4  1
1996 Armstrong JM, Vitetta ES. The roles of Fas and perforin in LAK T-cell/bispecific antibody-mediated killing of the murine B-lymphoma cells, BCL1. International Journal of Cancer. Journal International Du Cancer. 68: 822-7. PMID 8980190 DOI: 10.1002/(SICI)1097-0215(19961211)68:6<822::AID-IJC22>3.0.CO;2-0  1
1996 Uhr JW, Marches R, Racila E, Tucker TF, Hsueh R, Street NE, Vitetta ES, Scheuermann RH. Role of antibody signaling in inducing tumor dormancy. Advances in Experimental Medicine and Biology. 406: 69-74. PMID 8910672 DOI: 10.1007/978-1-4899-0274-0_7  1
1996 Ghetie MA, Podar EM, Gordon BE, Pantazis P, Uhr JW, Vitetta ES. Combination immunotoxin treatment and chemotherapy in SCID mice with advanced, disseminated Daudi lymphoma. International Journal of Cancer. Journal International Du Cancer. 68: 93-6. PMID 8895546 DOI: 10.1002/(SICI)1097-0215(19960927)68:1<93::AID-IJC16>3.0.CO;2-7  1
1996 Ramilo O, Hicks PJ, Borvak J, Gross LM, Zhong D, Squires JE, Vitetta ES. T cell activation and human immunodeficiency virus replication after influenza immunization of infected children. The Pediatric Infectious Disease Journal. 15: 197-203. PMID 8852906 DOI: 10.1097/00006454-199603000-00004  1
1996 Borvak J, Chou CS, Van Dyke G, Rosenwirth B, Vitetta ES, Ramilo O. The use of cyclosporine, FK506, and SDZ NIM811 to prevent CD25- quiescent peripheral blood mononuclear cells from producing human immunodeficiency virus. The Journal of Infectious Diseases. 174: 850-3. PMID 8843228  1
1996 Ghetie MA, Gordon BE, Podar EM, Vitetta ES. Effect of sublethal irradiation of SCID mice on growth of B-cell lymphoma xenografts and on efficacy of chemotherapy and/or immunotoxin therapy. Laboratory Animal Science. 46: 305-9. PMID 8799937  1
1996 Thrush GR, Lark LR, Clinchy BC, Vitetta ES. Immunotoxins: an update. Annual Review of Immunology. 14: 49-71. PMID 8717507 DOI: 10.1146/annurev.immunol.14.1.49  1
1996 Stone MJ, Sausville EA, Fay JW, Headlee D, Collins RH, Figg WD, Stetler-Stevenson M, Jain V, Jaffe ES, Solomon D, Lush RM, Senderowicz A, Ghetie V, Schindler J, Uhr JW, ... Vitetta ES, et al. A phase I study of bolus versus continuous infusion of the anti-CD19 immunotoxin, IgG-HD37-dgA, in patients with B-cell lymphoma. Blood. 88: 1188-97. PMID 8695836 DOI: 10.1182/Blood.V88.4.1188.Bloodjournal8841188  1
1996 Ghetie MA, Ghetie V, Vitetta ES. The use of immunoconjugates in cancer therapy Expert Opinion On Investigational Drugs. 5: 309-321.  1
1995 Burrows FJ, Derbyshire EJ, Tazzari PL, Amlot P, Gazdar AF, King SW, Letarte M, Vitetta ES, Thorpe PE. Up-regulation of endoglin on vascular endothelial cells in human solid tumors: implications for diagnosis and therapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 1: 1623-34. PMID 9815965  1
1995 Marches R, Racila E, Tucker TF, Picker L, Mongini P, Hsueh R, Vitetta ES, Scheuermann RH, Uhr JW. Tumour dormancy and cell signalling--III: Role of hypercrosslinking of IgM and CD40 on the induction of cell cycle arrest and apoptosis in B lymphoma cells. Therapeutic Immunology. 2: 125-36. PMID 8885131  1
1995 Conry RM, Khazaeli MB, Saleh MN, Ghetie V, Vitetta ES, Liu T, LoBuglio AF. Phase I trial of an anti-CD19 deglycosylated ricin A chain immunotoxin in non-Hodgkin's lymphoma: effect of an intensive schedule of administration. Journal of Immunotherapy With Emphasis On Tumor Immunology : Official Journal of the Society For Biological Therapy. 18: 231-41. PMID 8680651  1
1995 Ghetie V, Engert A, Schnell R, Vitetta ES. The in vivo anti-tumor activity of immunotoxins containing two versus one deglycosylated ricin A chains. Cancer Letters. 98: 97-101. PMID 8529213 DOI: 10.1016/S0304-3835(06)80016-9  1
1995 Huang YW, Richardson JA, Vitetta ES. Anti-CD54 (ICAM-1) has antitumor activity in SCID mice with human myeloma cells. Cancer Research. 55: 610-6. PMID 7834632  1
1995 Sausville EA, Headlee D, Stetler-Stevenson M, Jaffe ES, Solomon D, Figg WD, Herdt J, Kopp WC, Rager H, Steinberg SM, Ghetie V, Schindler J, Uhr J, Wittes RE, Vitetta ES. Continuous infusion of the anti-CD22 immunotoxin IgG-RFB4-SMPT-dgA in patients with B-cell lymphoma: A phase I study Blood. 85: 3457-3465. PMID 7780133  1
1995 Lee WT, Thrush GR, Vitetta ES. Staphylococcal enterotoxin B induces the expression of activation markers on murine memory T cells in the absence of proliferation or lymphokine secretion. Cellular Immunology. 162: 26-32. PMID 7704907 DOI: 10.1006/cimm.1995.1047  1
1995 Borvak J, Chou CS, Bell K, Van Dyke G, Zola H, Ramilo O, Vitetta ES. Expression of CD25 defines peripheral blood mononuclear cells with productive versus latent HIV infection. Journal of Immunology (Baltimore, Md. : 1950). 155: 3196-204. PMID 7673732  1
1995 Huang YW, Vitetta ES. Immunotherapy of multiple myeloma. Stem Cells (Dayton, Ohio). 13: 123-34. PMID 7540468 DOI: 10.1002/stem.5530130204  1
1995 Racila E, Scheuermann RH, Picker LJ, Yefenof E, Tucker T, Chang W, Marches R, Street NE, Vitetta ES, Uhr JW. Tumor dormancy and cell signaling. II. Antibody as an agonist in inducing dormancy of a B cell lymphoma in SCID mice. The Journal of Experimental Medicine. 181: 1539-50. PMID 7535341 DOI: 10.1084/jem.181.4.1539  1
1994 Shen GL, Li JL, Vitetta ES. Bispecific anti-CD22/anti-CD3-ricin A chain immunotoxin is cytotoxic to Daudi lymphoma cells but not T cells in vitro and shows both A-chain-mediated and LAK-T-mediated killing. Journal of Immunology (Baltimore, Md. : 1950). 152: 2368-76. PMID 8133047  1
1994 Vitetta ES. From the basic science of B cells to biological missiles at the bedside. Journal of Immunology (Baltimore, Md. : 1950). 153: 1407-20. PMID 8046221  1
1994 Vitetta ES, Uhr JW. Monoclonal antibodies as agonists: an expanded role for their use in cancer therapy. Cancer Research. 54: 5301-9. PMID 7923157  1
1994 Ghetie V, Vitetta E. Immunotoxins in the therapy of cancer: from bench to clinic. Pharmacology & Therapeutics. 63: 209-34. PMID 7831391 DOI: 10.1016/0163-7258(94)90025-6  1
1994 Ghetie MA, Vitetta ES. Recent developments in immunotoxin therapy. Current Opinion in Immunology. 6: 707-14. PMID 7826525 DOI: 10.1016/0952-7915(94)90073-6  1
1994 Ghetie MA, Tucker K, Richardson J, Uhr JW, Vitetta ES. Eradication of minimal disease in severe combined immunodeficient mice with disseminated Daudi lymphoma using chemotherapy and an immunotoxin cocktail. Blood. 84: 702-7. PMID 7519071 DOI: 10.1182/Blood.V84.3.702.Bloodjournal843702  1
1994 Scheuermann RH, Racila E, Tucker T, Yefenof E, Street NE, Vitetta ES, Picker LJ, Uhr JW. Lyn tyrosine kinase signals cell cycle arrest but not apoptosis in B-lineage lymphoma cells. Proceedings of the National Academy of Sciences of the United States of America. 91: 4048-52. PMID 7513431 DOI: 10.1073/Pnas.91.9.4048  1
1994 Ghetie MA, Picker LJ, Richardson JA, Tucker K, Uhr JW, Vitetta ES. Anti-CD19 inhibits the growth of human B-cell tumor lines in vitro and of Daudi cells in SCID mice by inducing cell cycle arrest. Blood. 83: 1329-36. PMID 7509655 DOI: 10.1182/Blood.V83.5.1329.Bloodjournal8351329  1
1993 Ramilo O, Bell KD, Uhr JW, Vitetta ES. Role of CD25+ and CD25-T cells in acute HIV infection in vitro. Journal of Immunology (Baltimore, Md. : 1950). 150: 5202-8. PMID 8496611  1
1993 Yefenof E, Picker LJ, Scheuermann RH, Tucker TF, Vitetta ES, Uhr JW. Cancer dormancy: isolation and characterization of dormant lymphoma cells. Proceedings of the National Academy of Sciences of the United States of America. 90: 1829-33. PMID 8446596 DOI: 10.1073/Pnas.90.5.1829  1
1993 Huang YW, Richardson JA, Tong AW, Zhang BQ, Stone MJ, Vitetta ES. Disseminated growth of a human multiple myeloma cell line in mice with severe combined immunodeficiency disease. Cancer Research. 53: 1392-6. PMID 8443818  1
1993 Bell KD, Ramilo O, Vitetta ES. Combined use of an immunotoxin and cyclosporine to prevent both activated and quiescent peripheral blood T cells from producing type 1 human immunodeficiency virus. Proceedings of the National Academy of Sciences of the United States of America. 90: 1411-5. PMID 8434001  1
1993 Vitetta ES, Thorpe PE, Uhr JW. Immunotoxins: magic bullets or misguided missiles? Immunology Today. 14: 252-9. PMID 8397766 DOI: 10.1016/0167-5699(93)90041-I  1
1993 Tong AW, Huang YW, Zhang BQ, Netto G, Vitetta ES, Stone MJ. Heterotransplantation of human multiple myeloma cell lines in severe combined immunodeficiency (SCID) mice. Anticancer Research. 13: 593-7. PMID 8391243  1
1993 Soler-Rodríguez AM, Ghetie MA, Oppenheimer-Marks N, Uhr JW, Vitetta ES. Ricin A-chain and ricin A-chain immunotoxins rapidly damage human endothelial cells: implications for vascular leak syndrome. Experimental Cell Research. 206: 227-34. PMID 8388800 DOI: 10.1006/excr.1993.1142  1
1993 Huang YW, Vitetta ES. A monoclonal anti-human IL-6 receptor antibody inhibits the proliferation of human myeloma cells. Hybridoma. 12: 621-30. PMID 8300137  1
1993 Yefenof E, Picker LJ, Scheuermann RH, Vitetta ES, Street NE, Tucker TF, Uhr JW. Induction of B cell tumor dormancy by anti-idiotypic antibodies. Current Opinion in Immunology. 5: 740-4. PMID 8240736 DOI: 10.1016/0952-7915(93)90130-K  1
1993 Ghetie V, Swindell E, Uhr JW, Vitetta ES. Purification and properties of immunotoxins containing one vs. two deglycosylated ricin A chains. Journal of Immunological Methods. 166: 117-22. PMID 8228282 DOI: 10.1016/0022-1759(93)90335-5  1
1993 Amlot PL, Stone MJ, Cunningham D, Fay J, Newman J, Collins R, May R, McCarthy M, Richardson J, Ghetie V, Ramilo O, Thorpe PE, Uhr JW, Vitetta ES. A phase I study of an anti-CD22-deglycosylated ricin a chain immunotoxin in the treatment of B-cell lymphomas resistant to conventional therapy Blood. 82: 2624-2633. PMID 8219217  1
1993 Vitetta ES, Thorpe PE, Uhr JW. Immunotoxins: magic bullets or misguided missiles? Trends in Pharmacological Sciences. 14: 148-54. PMID 8212309 DOI: 10.1016/0165-6147(93)90199-T  1
1993 Huang YW, Burrows FJ, Vitetta ES. Cytotoxicity of a novel anti-ICAM-1 immunotoxin on human myeloma cell lines. Hybridoma. 12: 661-75. PMID 7904588  1
1993 Thorpe P, Stone M, Amlot P, Fay J, Collins R, Cunningham D, McCarthy M, Ghetie V, Sausville E, Uhr J, Vitetta ES. The development of immunotoxins for the treatment of B-cell lymphoma Leukemia. 7: 1487.  1
1992 Yefenof E, Ela C, Kotler M, Vitetta ES. Induction of IL-4 secretion by the radiation leukemia virus (RadLV): role in autocrine growth stimulation of RadLV infected pre-leukemic cells. International Journal of Cancer. Journal International Du Cancer. 50: 481-5. PMID 1735616  1
1992 Yefenof E, Abboud G, Epszteyn S, Vitetta ES. Treatment of premalignancy: prevention of lymphoma in radiation leukemia virus-inoculated mice by cyclosporin A and immunotoxin. Proceedings of the National Academy of Sciences of the United States of America. 89: 728-32. PMID 1731346  1
1992 Soler-Rodriguez AM, Uhr JW, Richardson J, Vitetta ES. The toxicity of chemically deglycosylated ricin A-chain in mice. International Journal of Immunopharmacology. 14: 281-91. PMID 1624227 DOI: 10.1016/0192-0561(92)90041-I  1
1992 Yin XM, Vitetta ES. The lineage relationship between virgin and memory B cells. International Immunology. 4: 691-8. PMID 1616900 DOI: 10.1093/intimm/4.6.691  1
1992 Lee WT, Vitetta ES. Memory T cells are anergic to the superantigen staphylococcal enterotoxin B. The Journal of Experimental Medicine. 176: 575-9. PMID 1500861  1
1992 Ghetie V, Wheeler T, Scott D, Uhr JW, Vitetta ES. A CD4-derived peptide carrier blocks acute HIV-1 infection in vitro and binds to gp120 in the presence of Walter-Reed stage 1-6 HIV+ sera. Aids Research and Human Retroviruses. 8: 1945-8. PMID 1489581 DOI: 10.1089/Aid.1992.8.1945  1
1992 Ghetie MA, Tucker K, Richardson J, Uhr JW, Vitetta ES. The antitumor activity of an anti-CD22 immunotoxin in SCID mice with disseminated Daudi lymphoma is enhanced by either an anti-CD19 antibody or an anti-CD19 immunotoxin. Blood. 80: 2315-20. PMID 1384801 DOI: 10.1182/Blood.V80.9.2315.Bloodjournal8092315  1
1992 Berton MT, Vitetta ES. IL-4-induced expression of germline gamma 1 transcripts in B cells following cognate interactions with T helper cells. International Immunology. 4: 387-96. PMID 1373644 DOI: 10.1093/Intimm/4.3.387  1
1992 Lee WT, Vitetta ES. Changes in expression of CD45R during the development of Th1 and Th2 cell lines. European Journal of Immunology. 22: 1455-9. PMID 1350982 DOI: 10.1002/eji.1830220618  1
1991 Ghetie V, Slaughter C, Wheeler HT, Uhr JW, Vitetta ES. CD4 peptide-protein conjugates, but not recombinant human CD4, bind to recombinant gp120 from the human immunodeficiency virus in the presence of serum from AIDS patients. Proceedings of the National Academy of Sciences of the United States of America. 88: 5690-3. PMID 2062847 DOI: 10.1073/Pnas.88.13.5690  1
1991 Vitetta ES, Thorpe PE. Immunotoxins containing ricin or its A chain. Seminars in Cell Biology. 2: 47-58. PMID 1954343  1
1991 Ghetie MA, Richardson J, Tucker T, Jones D, Uhr JW, Vitetta ES. Antitumor activity of Fab' and IgG-anti-CD22 immunotoxins in disseminated human B lymphoma grown in mice with severe combined immunodeficiency disease: effect on tumor cells in extranodal sites. Cancer Research. 51: 5876-80. PMID 1933855  1
1991 Burger C, Vitetta ES. The response of B cells in spleen, Peyer's patches, and lymph nodes to LPS and IL-4. Cellular Immunology. 138: 35-43. PMID 1913841 DOI: 10.1016/0008-8749(91)90130-4  1
1991 Vitetta ES, Berton MT, Burger C, Kepron M, Lee WT, Yin XM. Memory B and T cells. Annual Review of Immunology. 9: 193-217. PMID 1910676 DOI: 10.1146/Annurev.Iy.09.040191.001205  1
1991 Bossie A, Vitetta ES. IFN-gamma enhances secretion of IgG2a from IgG2a-committed LPS-stimulated murine B cells: implications for the role of IFN-gamma in class switching. Cellular Immunology. 135: 95-104. PMID 1902147 DOI: 10.1016/0008-8749(91)90257-C  1
1991 Yin XM, Lee WT, Vitetta ES. Changes in expression of J11d on murine B cells during activation and generation of memory. Cellular Immunology. 137: 448-60. PMID 1893407 DOI: 10.1016/0008-8749(91)90093-Q  1
1991 Uhr JW, Tucker T, May RD, Siu H, Vitetta ES. Cancer dormancy: studies of the murine BCL1 lymphoma. Cancer Research. 51: 5045s-5053s. PMID 1884380  1
1991 Fernandez-Botran R, Vitetta ES. Evidence that natural murine soluble interleukin 4 receptors may act as transport proteins. The Journal of Experimental Medicine. 174: 673-81. PMID 1875167  1
1991 Vitetta ES, Stone M, Amlot P, Fay J, May R, Till M, Newman J, Clark P, Collins R, Cunningham D. Phase I immunotoxin trial in patients with B-cell lymphoma. Cancer Research. 51: 4052-8. PMID 1855219  1
1991 Lee WT, Vitetta ES. Virgin T cells do not provide help for antigen-specific B cells in the absence of IL-4, IL-5, and IL-6. International Immunology. 3: 907-16. PMID 1834163 DOI: 10.1093/intimm/3.9.907  1
1991 Ghetie V, Thorpe P, Ghetie MA, Knowles P, Uhr JW, Vitetta ES. The GLP large scale preparation of immunotoxins containing deglycosylated ricin A chain and a hindered disulfide bond. Journal of Immunological Methods. 142: 223-30. PMID 1717600 DOI: 10.1016/0022-1759(91)90110-2  1
1991 Yin XM, Vitetta ES. IL-4 down-regulates the expression of J11d on murine B cells. Cellular Immunology. 137: 461-73. PMID 1716522 DOI: 10.1016/0008-8749(91)90094-R  1
1991 May RD, Wheeler HT, Finkelman FD, Uhr JW, Vitetta ES. Intracellular routing rather than cross-linking or rate of internalization determines the potency of immunotoxins directed against different epitopes of sIgD on murine B cells. Cellular Immunology. 135: 490-500. PMID 1709828 DOI: 10.1016/0008-8749(91)90292-J  1
1991 Ghetie MA, Uhr JW, Vitetta ES. Covalent binding of human alpha 2-macroglobulin to deglycosylated ricin A chain and its immunotoxins. Cancer Research. 51: 1482-7. PMID 1705175  1
1991 Sanders VM, Vitetta ES. B cell-associated LFA-1 and T cell-associated ICAM-1 transiently cluster in the area of contact between interacting cells. Cellular Immunology. 132: 45-55. PMID 1676615 DOI: 10.1016/0008-8749(91)90005-V  1
1991 Lee WT, Vitetta ES. The differential expression of homing and adhesion molecules on virgin and memory T cells in the mouse. Cellular Immunology. 132: 215-22. PMID 1676613 DOI: 10.1016/0008-8749(91)90020-C  1
1990 Berton MT, Vitetta ES. Interleukin 4 induces changes in the chromatin structure of the gamma 1 switch region in resting B cells before switch recombination. The Journal of Experimental Medicine. 172: 375-8. PMID 2358783 DOI: 10.1084/Jem.172.1.375  1
1990 Fernandez-Botran R, Vitetta ES. A soluble, high-affinity, interleukin-4-binding protein is present in the biological fluids of mice. Proceedings of the National Academy of Sciences of the United States of America. 87: 4202-6. PMID 2349230  1
1990 Ghetie MA, Richardson J, Tucker T, Jones D, Uhr JW, Vitetta ES. Disseminated or localized growth of a human B-cell tumor (Daudi) in SCID mice. International Journal of Cancer. Journal International Du Cancer. 45: 481-5. PMID 2307538 DOI: 10.1002/Ijc.2910450318  1
1990 Ghetie V, Till MA, Ghetie MA, Uhr JW, Vitetta ES. Large scale preparation of an immunoconjugate constructed with human recombinant CD4 and deglycosylated ricin A chain. Journal of Immunological Methods. 126: 135-41. PMID 2303721 DOI: 10.1016/0022-1759(90)90021-M  1
1990 Lee WT, Vitetta ES. Limiting dilution analysis of CD45Rhi and CD45Rlo T cells: further evidence that CD45Rlo cells are memory cells. Cellular Immunology. 130: 459-71. PMID 2145081 DOI: 10.1016/0008-8749(90)90287-2  1
1990 Till MA, Ghetie V, May RD, Auerbach PC, Zolla-Pazner S, Gorny MK, Gregory T, Uhr JW, Vitetta ES. Immunoconjugates containing ricin A chain and either human anti-gp41 or CD4 kill H9 cells infected with different isolates of HIV, but do not inhibit normal T or B cell function. Journal of Acquired Immune Deficiency Syndromes. 3: 609-14. PMID 2140127  1
1990 Stevens TL, Vitetta ES. Antigen-specific sIalo B cells do not secrete IgG2a in response to TH1 cells and antigen: responsiveness can be restored by IL-4. Journal of Immunology (Baltimore, Md. : 1950). 144: 869-74. PMID 2136902  1
1990 O'Hare M, Brown AN, Hussain K, Gebhardt A, Watson G, Roberts LM, Vitetta ES, Thorpe PE, Lord JM. Cytotoxicity of a recombinant ricin-A-chain fusion protein containing a proteolytically-cleavable spacer sequence. Febs Letters. 273: 200-4. PMID 2121540 DOI: 10.1016/0014-5793(90)81084-2  1
1990 Ghetie V, Till MA, Ghetie MA, Tucker T, Porter J, Patzer EJ, Richardson JA, Uhr JW, Vitetta ES. Preparation and characterization of conjugates of recombinant CD4 and deglycosylated ricin A chain using different cross-linkers. Bioconjugate Chemistry. 1: 24-31. PMID 2095203 DOI: 10.1021/Bc00001A003  1
1990 Vitetta ES. Immunotoxins: new therapeutic reagents for autoimmunity, cancer, and AIDS. Journal of Clinical Immunology. 10: 15S-18S. PMID 2081785 DOI: 10.1007/BF00918687  1
1990 Lee WT, Yin XM, Vitetta ES. Functional and ontogenetic analysis of murine CD45Rhi and CD45Rlo CD4+ T cells. Journal of Immunology (Baltimore, Md. : 1950). 144: 3288-95. PMID 1970350  1
1990 Vitetta ES, Yen N. Expression and functional properties of genetically engineered ricin B chain lacking galactose-binding activity. Biochimica Et Biophysica Acta. 1049: 151-7. PMID 1694694 DOI: 10.1016/0167-4781(90)90035-Z  1
1990 May RD, Finkelman FD, Wheeler HT, Uhr JW, Vitetta ES. Evaluation of ricin A chain-containing immunotoxins directed against different epitopes on the delta-chain of cell surface-associated IgD on murine B cells. Journal of Immunology (Baltimore, Md. : 1950). 144: 3637-42. PMID 1691764  1
1990 Thorpe P, Knowles P, Ghetie V, Till M, Amlot P, Janossy G, Stone M, Fay J, Uhr J, Vitetta E. Selective killing of malignant cells fey antibody-ricin conjugates ('immunotoxins') European Journal of Pharmacology. 183: 146-147. DOI: 10.1016/0014-2999(90)91415-8  1
1989 Kepron MR, Chen YW, Uhr JW, Vitetta ES. IL-4 induces the specific rearrangement of gamma 1 genes on the expressed and unexpressed chromosomes of lipopolysaccharide-activated normal murine B cells. Journal of Immunology (Baltimore, Md. : 1950). 143: 334-9. PMID 2786532  1
1989 Fernandez-Botran R, Uhr JW, Vitetta ES. Cross-linking of interleukin 4 to surface molecules on murine T and B lymphocytes. Proceedings of the National Academy of Sciences of the United States of America. 86: 4235-9. PMID 2786209  1
1989 Uhr JW, Fulton RJ, Till MA, May RD, Vitetta ES. Monoclonal antibodies as carriers of toxins. Progress in Clinical and Biological Research. 288: 403-12. PMID 2785694  1
1989 Vitetta ES, Fernandez-Botran R, Myers CD, Sanders VM. Cellular interactions in the humoral immune response. Advances in Immunology. 45: 1-105. PMID 2665437  0.8
1989 Fernandez-Botran R, Sanders VM, Vitetta ES. Regulation of the biological effects of IL-4 on murine T and B cells. Cold Spring Harbor Symposia On Quantitative Biology. 54: 705-11. PMID 2640625  1
1989 Myers CD, Vitetta ES. The processing of antigen and anti-Ig by antigen-specific B cells. The Journal of Molecular and Cellular Immunology : Jmci. 4: 179-87; discussion 1. PMID 2610853  1
1989 Till MA, Zolla-Pazner S, Gorny MK, Patton JS, Uhr JW, Vitetta ES. Human immunodeficiency virus-infected T cells and monocytes are killed by monoclonal human anti-gp41 antibodies coupled to ricin A chain. Proceedings of the National Academy of Sciences of the United States of America. 86: 1987-91. PMID 2538826  1
1989 Street NE, Uyemura K, Sanders VM, Uhr JW, Vitetta ES. In vivo administration of Fab' fragments of anti-L3T4 (GK1.5) antibody inhibits the T helper cell function of murine lymph node cells. Cellular Immunology. 120: 75-81. PMID 2522831 DOI: 10.1016/0008-8749(89)90175-5  1
1989 Fernandez-Botran R, Sanders VM, Vitetta ES. Interactions between receptors for interleukin 2 and interleukin 4 on lines of helper T cells (HT-2) and B lymphoma cells (BCL1). The Journal of Experimental Medicine. 169: 379-91. PMID 2521354  1
1989 Berton MT, Uhr JW, Vitetta ES. Synthesis of germ-line gamma 1 immunoglobulin heavy-chain transcripts in resting B cells: induction by interleukin 4 and inhibition by interferon gamma. Proceedings of the National Academy of Sciences of the United States of America. 86: 2829-33. PMID 2495537 DOI: 10.1073/Pnas.86.8.2829  1
1989 Myers CD, Vitetta ES. Splenic B cells and antigen-specific B cells process anti-Ig in a similar manner. Cellular Immunology. 121: 174-84. PMID 2470517 DOI: 10.1016/0008-8749(89)90015-4  1
1988 Ghetie V, Ghetie MA, Uhr JW, Vitetta ES. Large scale preparation of immunotoxins constructed with the Fab' fragment of IgG1 murine monoclonal antibodies and chemically deglycosylated ricin A chain. Journal of Immunological Methods. 112: 267-77. PMID 3262139 DOI: 10.1016/0022-1759(88)90367-5  1
1988 Fulton RJ, Uhr JW, Vitetta ES. In vivo therapy of the BCL1 tumor: effect of immunotoxin valency and deglycosylation of the ricin A chain. Cancer Research. 48: 2626-31. PMID 3258547  1
1988 Fulton RJ, Tucker TF, Vitetta ES, Uhr JW. Pharmacokinetics of tumor-reactive immunotoxins in tumor-bearing mice: effect of antibody valency and deglycosylation of the ricin A chain on clearance and tumor localization. Cancer Research. 48: 2618-25. PMID 3258546  1
1988 Till M, May RD, Uhr JW, Thorpe PE, Vitetta ES. An assay that predicts the ability of monoclonal antibodies to form potent ricin A chain-containing immunotoxins. Cancer Research. 48: 1119-23. PMID 3257712  1
1988 Vitetta ES. The development of immunotoxins for the therapy of cancer, AIDS, and immune dysfunctions. Princess Takamatsu Symposia. 19: 333-40. PMID 3077626  1
1988 Fernandez-Botran R, Sanders VM, Mosmann TR, Vitetta ES. Lymphokine-mediated regulation of the proliferative response of clones of T helper 1 and T helper 2 cells. The Journal of Experimental Medicine. 168: 543-58. PMID 2970518 DOI: 10.1084/Jem.168.2.543  1
1988 Till MA, Ghetie V, Gregory T, Patzer EJ, Porter JP, Uhr JW, Capon DJ, Vitetta ES. HIV-infected cells are killed by rCD4-ricin A chain. Science (New York, N.Y.). 242: 1166-8. PMID 2847316 DOI: 10.1126/Science.2847316  1
1988 Birkeland ML, Metlay J, Sanders VM, Fernandez-Botran R, Vitetta ES, Steinman RM, Puré E. Epitopes on CD45R [T200] molecules define differentiation antigens on murine B and T lymphocytes. The Journal of Molecular and Cellular Immunology : Jmci. 4: 71-85. PMID 2475124  0.8
1988 Press OW, Martin PJ, Thorpe PE, Vitetta ES. Ricin A-chain containing immunotoxins directed against different epitopes on the CD2 molecule differ in their ability to kill normal and malignant T cells. Journal of Immunology (Baltimore, Md. : 1950). 141: 4410-7. PMID 2461993  1
1988 Sanders VM, Fernandez-Botran R, Coffman RL, Mosmann TR, Vitetta ES. A single antigen-specific B cell can conjugate to either a type 1 or a type 2 helper T cell. Proceedings of the National Academy of Sciences of the United States of America. 85: 7724-8. PMID 2459715 DOI: 10.1073/Pnas.85.20.7724  1
1988 Stevens TL, Bossie A, Sanders VM, Fernandez-Botran R, Coffman RL, Mosmann TR, Vitetta ES. Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells. Nature. 334: 255-8. PMID 2456466 DOI: 10.1038/334255A0  1
1987 Bossie A, Brooks KH, Krammer PH, Vitetta ES. Activation of murine B cells from different tissues with different mitogens. II. Isotype distribution of secreted immunoglobulins in the presence and absence of IL-4-containing T cell supernatants. The Journal of Molecular and Cellular Immunology : Jmci. 3: 221-6. PMID 3509924  0.6
1987 Myers CD, Sanders VM, Yefenof E, Oliver KG, Uhr JW, Vitetta ES. Purification and characterization of antigen-binding virgin and memory B cells. Methods in Enzymology. 150: 316-25. PMID 3501520  1
1987 Vitetta ES, Fulton RJ, May RD, Till M, Uhr JW. Redesigning nature's poisons to create anti-tumor reagents. Science (New York, N.Y.). 238: 1098-104. PMID 3317828 DOI: 10.1126/Science.3317828  1
1987 Chang MS, Russell DW, Uhr JW, Vitetta ES. Cloning and expression of recombinant, functional ricin B chain. Proceedings of the National Academy of Sciences of the United States of America. 84: 5640-4. PMID 3112772 DOI: 10.1073/Pnas.84.16.5640  1
1987 Oliver K, Krammer PH, Tucker PW, Vitetta ES. The effects of cytokines and adherent cells on the interleukin 4-mediated induction of Ia antigens on resting B cells. Cellular Immunology. 106: 428-36. PMID 3105899 DOI: 10.1016/0008-8749(87)90185-7  1
1987 Sanders VM, Fernandez-Botran R, Uhr JW, Vitetta ES. Interleukin 4 enhances the ability of antigen-specific B cells to form conjugates with T cells. Journal of Immunology (Baltimore, Md. : 1950). 139: 2349-54. PMID 2958546  1
1987 Street NE, Fulton RJ, Sanders VM, Vitetta ES. Inhibition of the helper function of murine T cells with Fab'-anti-L3T4 ricin A chain immunotoxin. Journal of Immunology (Baltimore, Md. : 1950). 139: 1734-8. PMID 2957434  1
1987 Sanders VM, Uhr JW, Vitetta ES. Antigen-specific memory and virgin B cells differ in their requirements for conjugation to T cells. Cellular Immunology. 104: 419-25. PMID 2949857 DOI: 10.1016/0008-8749(87)90043-8  1
1987 Brooks KH, Vitetta ES. Activation of murine B cells with Salmonella typhimurium mitogen (STM), lipopolysaccharide (LPS), and dextran sulfate (DxS). I. Cell-cycle analysis and induction of cytoplasmic immunoglobulin. The Journal of Molecular and Cellular Immunology : Jmci. 3: 215-9. PMID 2473769  1
1987 Vitetta ES, Bossie A, Fernandez-Botran R, Myers CD, Oliver KG, Sanders VM, Stevens TL. Interaction and activation of antigen-specific T and B cells. Immunological Reviews. 99: 193-239. PMID 2445658  1
1986 Fulton RJ, Uhr JW, Vitetta ES. The effect of antibody valency and lysosomotropic amines on the synergy between ricin A chain- and ricin B chain-containing immunotoxins. Journal of Immunology (Baltimore, Md. : 1950). 136: 3103-9. PMID 3958490  1
1986 Fulton RJ, Blakey DC, Knowles PP, Uhr JW, Thorpe PE, Vitetta ES. Purification of ricin A1, A2, and B chains and characterization of their toxicity. The Journal of Biological Chemistry. 261: 5314-9. PMID 3957927  1
1986 Siu H, Vitetta ES, May RD, Uhr JW. Tumor dormancy. I. Regression of BCL1 tumor and induction of a dormant tumor state in mice chimeric at the major histocompatibility complex. Journal of Immunology (Baltimore, Md. : 1950). 137: 1376-82. PMID 3525678  1
1986 Press OW, Vitetta ES, Martin PJ. A simplified microassay for inhibition of protein synthesis in reticulocyte lysates by immunotoxins. Immunology Letters. 14: 37-41. PMID 3492442 DOI: 10.1016/0165-2478(86)90017-9  1
1986 Myers CD, Sanders VM, Vitetta ES. Isolation of antigen-binding virgin and memory B cells. Journal of Immunological Methods. 92: 45-57. PMID 3489048  0.8
1986 Noelle RJ, Kuziel WA, Maliszewski CR, McAdams E, Vitetta ES, Tucker PW. Regulation of the expression of multiple class II genes in murine B cells by B cell stimulatory factor-1 (BSF-1). Journal of Immunology (Baltimore, Md. : 1950). 137: 1718-23. PMID 3489040  1
1986 Mishra GC, Berton MT, Oliver KG, Krammer PH, Uhr JW, Vitetta ES. A monoclonal anti-mouse LFA-1 alpha antibody mimics the biological effects of B cell stimulatory factor-1 (BSF-1). Journal of Immunology (Baltimore, Md. : 1950). 137: 1590-8. PMID 3091687  1
1986 Chen YW, Word C, Dev V, Uhr JW, Vitetta ES, Tucker PW. Double isotype production by a neoplastic B cell line. II. Allelically excluded production of mu and gamma 1 heavy chains without CH gene rearrangement. The Journal of Experimental Medicine. 164: 562-79. PMID 3088208 DOI: 10.1084/Jem.164.2.562  1
1986 Fernandez-Botran R, Sanders VM, Oliver KG, Chen YW, Krammer PH, Uhr JW, Vitetta ES. Interleukin 4 mediates autocrine growth of helper T cells after antigenic stimulation. Proceedings of the National Academy of Sciences of the United States of America. 83: 9689-93. PMID 2948185 DOI: 10.1073/Pnas.83.24.9689  1
1986 Brooks KH, Vitetta ES. Recombinant IL 2 but not recombinant interferon-gamma stimulates both proliferation and IgM secretion in a Ly-1+ clone of neoplastic murine B cells (BCL1). Journal of Immunology (Baltimore, Md. : 1950). 137: 3205-10. PMID 2945863  1
1986 Sanders VM, Snyder JM, Uhr JW, Vitetta ES. Characterization of the physical interaction between antigen-specific B and T cells. Journal of Immunology (Baltimore, Md. : 1950). 137: 2395-404. PMID 2944954  1
1986 Fernandez-Botran R, Krammer PH, Diamantstein T, Uhr JW, Vitetta ES. B cell-stimulatory factor 1 (BSF-1) promotes growth of helper T cell lines. The Journal of Experimental Medicine. 164: 580-93. PMID 2941517 DOI: 10.1084/Jem.164.2.580  1
1986 Shigeta M, Takahara S, Knox SJ, Ishihara T, Vitetta ES, Fathman CG. Two independent pathways of helper activity provided by a single T cell clone. Journal of Immunology (Baltimore, Md. : 1950). 136: 34-8. PMID 2933466  1
1986 Chen YW, Word CJ, Jones S, Uhr JW, Tucker PW, Vitetta ES. Double isotype production by a neoplastic B cell line. I. Cellular and biochemical characterization of a variant of BCL1 that expresses and secretes both IgM and IgG1. The Journal of Experimental Medicine. 164: 548-61. PMID 2425035 DOI: 10.1084/Jem.164.2.548  1
1986 Yefenof E, Sanders VM, Uhr JW, Vitetta ES. In vitro activation of murine antigen-specific memory B cells by a T-dependent antigen. Journal of Immunology (Baltimore, Md. : 1950). 137: 85-90. PMID 2423612  1
1986 Vitetta ES. Synergy between immunotoxins prepared with native ricin A chains and chemically-modified ricin B chains. Journal of Immunology (Baltimore, Md. : 1950). 136: 1880-7. PMID 2419417  1
1985 Jones S, Layton J, Krammer PH, Vitetta ES, Tucker PW. The effect of T cell-derived lymphokines on the levels of isotype-specific RNA in normal B cells. The Journal of Molecular and Cellular Immunology : Jmci. 2: 143-53. PMID 3939752  1
1985 Brooks K, Fernandez R, Vitetta ES. B cell growth and differentiation factors. Methods in Enzymology. 116: 372-9. PMID 3937026  1
1985 Vitetta ES, Ohara J, Myers CD, Layton JE, Krammer PH, Paul WE. Serological, biochemical, and functional identity of B cell-stimulatory factor 1 and B cell differentiation factor for IgG1. The Journal of Experimental Medicine. 162: 1726-31. PMID 3932582 DOI: 10.1084/jem.162.5.1726  0.56
1985 Martin PJ, Hansen JA, Vitetta ES. A ricin A chain-containing immunotoxin that kills human T lymphocytes in vitro. Blood. 66: 908-12. PMID 3929860 DOI: 10.1182/Blood.V66.4.908.908  1
1985 Yuan D, Weiss EA, Layton JE, Krammer PH, Vitetta ES. Activation of the gamma 1 gene by lipopolysaccharide and T cell-derived lymphokines containing a B cell differentiation factor for IgG1 (BCDF gamma). Journal of Immunology (Baltimore, Md. : 1950). 135: 1465-9. PMID 3925011  0.56
1985 Vitetta ES, Uhr JW. Immunotoxins. Annual Review of Immunology. 3: 197-212. PMID 3904769 DOI: 10.1146/annurev.iy.03.040185.001213  1
1985 Vitetta ES, Uhr JW. Immunotoxins: redirecting nature's poisons. Cell. 41: 653-4. PMID 3891095 DOI: 10.1016/S0092-8674(85)80042-8  1
1985 Vitetta ES, Thorpe PE. Immunotoxins containing ricin A or B chains with modified carbohydrate residues act synergistically in killing neoplastic B cells in vitro. Cancer Drug Delivery. 2: 191-8. PMID 3876875  1
1985 Oliver K, Noelle RJ, Uhr JW, Krammer PH, Vitetta ES. B-cell growth factor (B-cell growth factor I or B-cell-stimulating factor, provisional 1) is a differentiation factor for resting B cells and may not induce cell growth. Proceedings of the National Academy of Sciences of the United States of America. 82: 2465-7. PMID 3873068 DOI: 10.1073/pnas.82.8.2465  1
1985 Brooks KH, Uhr JW, Vitetta ES. Cell cycle-related expression of the receptor for a B cell differentiation factor. Journal of Immunology (Baltimore, Md. : 1950). 134: 742-7. PMID 3871214  1
1985 Vitetta ES, Uhr JW. The use of immunotoxins containing ricin A or B chains to kill neoplastic B cells. Annals of the New York Academy of Sciences. 446: 228-36. PMID 3860153 DOI: 10.1111/J.1749-6632.1985.Tb18403.X  1
1985 Waldschmidt TJ, Layton JE, McFadden SF, Uhr JW, Vitetta ES. sIgD- and sIgD+ B cells responding to thymus-independent antigens have a different lymphokine requirement. Journal of Immunology (Baltimore, Md. : 1950). 135: 865-7. PMID 3159795  1
1985 Layton JE, Krammer PH, Hamaoka T, Uhr JW, Vitetta ES. Small and large B cells respond differently to T cell-derived B cell growth and differentiation factors. The Journal of Molecular and Cellular Immunology : Jmci. 2: 155-67. PMID 2978227  1
1985 Waldschmidt TJ, Vitetta ES. The use of haptenated-immunoglobulin molecules to induce tolerance in B cells from neonatal mice. Journal of Immunology (Baltimore, Md. : 1950). 134: 1436-41. PMID 2578508  1
1985 Yefenof E, Sanders VM, Snow EC, Noelle RJ, Oliver KG, Uhr JW, Vitetta ES. Preparation and analysis of antigen-specific memory B cells. Journal of Immunology (Baltimore, Md. : 1950). 135: 3777-84. PMID 2415585  1
1985 Street NE, Vitetta ES. Use of combinations of ricin A chain-containing immunotoxins to kill murine T lymphomas in vitro Federation Proceedings. 44.  1
1985 Waldschmidt T, Vitetta ES. Fc receptors on B-cells mediate down-regulation of antibody secretion Annales De L'Institut Pasteur - Immunology. 136: 417-420.  1
1984 Vitetta ES, Fulton RJ, Uhr JW. Cytotoxicity of a cell-reactive immunotoxin containing ricin A chain is potentiated by an anti-immunotoxin containing ricin B chain. The Journal of Experimental Medicine. 160: 341-6. PMID 6736871  1
1984 Cushley W, Muirhead MJ, Silva F, Greathouse J, Tucker T, Uhr JW, Vitetta ES. In vivo reconstitution of ricin-like activity from its A and B chain subunits. Toxicon : Official Journal of the International Society On Toxinology. 22: 265-77. PMID 6729842 DOI: 10.1016/0041-0101(84)90027-8  1
1984 Finkelman FD, Vitetta ES. Role of surface immunoglobulin in B lymphocyte activation. Federation Proceedings. 43: 2624-32. PMID 6611276  1
1984 McFadden SF, Vitetta ES. sIgD-negative B cells from neonatal mice do not respond to the thymus-independent antigen TNP-BA in limiting dilution cultures. Journal of Immunology (Baltimore, Md. : 1950). 132: 1717-21. PMID 6607945  1
1984 Layton JE, Vitetta ES, Uhr JW, Krammer PH. Clonal analysis of B cells induced to secrete IgG by T cell-derived lymphokine(s). The Journal of Experimental Medicine. 160: 1850-63. PMID 6439816 DOI: 10.1084/Jem.160.6.1850  1
1984 Noelle R, Krammer PH, Ohara J, Uhr JW, Vitetta ES. Increased expression of Ia antigens on resting B cells: an additional role for B-cell growth factor. Proceedings of the National Academy of Sciences of the United States of America. 81: 6149-53. PMID 6435125 DOI: 10.1073/pnas.81.19.6149  1
1984 Forman J, Riblet R, Brooks K, Vitetta ES, Henderson LA. H-40, an antigen controlled by an Igh linked gene and recognized by cytotoxic T lymphocytes. I. Genetic analysis of H-40 and distribution of its product on B cell tumors. The Journal of Experimental Medicine. 159: 1724-40. PMID 6427384  1
1984 Soloski MJ, Vitetta ES. Immunochemical purification and analysis of Qa and TL antigens. Methods in Enzymology. 108: 549-58. PMID 6396489 DOI: 10.1016/S0076-6879(84)08117-9  1
1984 Yuan D, Vitetta ES. Biosynthetic, surface labeling, and isolation of membrane immunoglobulin. Methods in Enzymology. 108: 426-33. PMID 6396486  1
1984 Vitetta ES, Uhr JW. The potential use of immunotoxins in transplantation, cancer therapy, and immunoregulation. Transplantation. 37: 535-8. PMID 6375011 DOI: 10.1097/00007890-198406000-00001  1
1984 Uhr JW, Vitetta ES. Deletion of neoplastic B cells by immunotoxins containing ricin A chains. Asian Pacific Journal of Allergy and Immunology / Launched by the Allergy and Immunology Society of Thailand. 2: 123-7. PMID 6335658  1
1984 Brooks KH, Uhr JW, Vitetta ES. A B cell growth factor-like activity is secreted by cloned, neoplastic B cells. Journal of Immunology (Baltimore, Md. : 1950). 133: 3133-7. PMID 6333454  1
1984 Brooks KH, Kuziel WA, Tucker PW, Uhr JW, Vitetta ES. Cloned neoplastic B cells release a growth factor which augments lymphokine-mediated proliferation of normal B cells. Current Topics in Microbiology and Immunology. 113: 69-71. PMID 6332721 DOI: 10.1007/978-3-642-69860-6_13  1
1984 Fulton RJ, Uhr JW, Vitetta ES. Synergy between ricin-A and ricin-B containing immunotoxins Federation Proceedings. 43: no. 3223.  1
1983 Jones S, Chen YW, Isakson P, Layton J, Pure E, Word C, Krammer PH, Tucker P, Vitetta ES. Effect of T cell-derived lymphokines containing B cell differentiation factor(s) for IgG (BCDF gamma) on gamma-specific mRNA in murine B cells. Journal of Immunology (Baltimore, Md. : 1950). 131: 3049-51. PMID 6605997  0.56
1983 Noelle RJ, Snow EC, Uhr JW, Vitetta ES. Activation of antigen-specific B cells: role of T cells, cytokines, and antigen in induction of growth and differentiation. Proceedings of the National Academy of Sciences of the United States of America. 80: 6628-31. PMID 6605533 DOI: 10.1073/pnas.80.21.6628  1
1983 Layton JE, Uhr JW, Pure E, Krammer PH, Vitetta ES. T cell-derived B cell growth (BCGF) and differentiation (BCDF) factors: suppression of the activity of BCDF mu but not BCGF by murine bone marrow cells. Journal of Immunology (Baltimore, Md. : 1950). 130: 2502-4. PMID 6602166  1
1983 Brooks K, Yuan D, Uhr JW, Krammer PH, Vitetta ES. Lymphokine-induced IgM secretion by clones of neoplastic B cells. Nature. 302: 825-6. PMID 6601774 DOI: 10.1038/302825a0  1
1983 Pure E, Isakson PC, Kappler JW, Marrack P, Krammer PH, Vitetta ES. T cell-derived B cell growth and differentiation factors. Dichotomy between the responsiveness of B cells from adult and neonatal mice. The Journal of Experimental Medicine. 157: 600-12. PMID 6600488 DOI: 10.1084/Jem.157.2.600  0.56
1983 Snow EC, Noelle RJ, Uhr JW, Vitetta ES. Activation of antigen-enriched B cells. II. Role of linked recognition in B cell proliferation to thymus-dependent antigens. Journal of Immunology (Baltimore, Md. : 1950). 130: 614-8. PMID 6600245  1
1983 Snow EC, Vitetta ES, Uhr JW. Activation of antigen-enriched b cells. I. Purification and response to thymus-independent antigens. Journal of Immunology (Baltimore, Md. : 1950). 130: 607-13. PMID 6600244  1
1983 Vitetta ES, Cushley W, Uhr JW. Synergy of ricin A chain-containing immunotoxins and ricin B chain-containing immunotoxins in in vitro killing of neoplastic human B cells. Proceedings of the National Academy of Sciences of the United States of America. 80: 6332-5. PMID 6578512 DOI: 10.1073/Pnas.80.20.6332  1
1983 Yagawa K, Vitetta ES. Induction of proliferation and differentiation of murine B cells bearing surface Ig lambda by rat monoclonal antibody to lambda chain. Hybridoma. 2: 169-75. PMID 6432681  1
1983 Muirhead M, Martin PJ, Torok-Storb B, Uhr JW, Vitetta ES. Use of an antibody-ricin A-chain conjugate to delete neoplastic B cells from human bone marrow. Blood. 62: 327-32. PMID 6409188 DOI: 10.1182/Blood.V62.2.327.Bloodjournal622327  1
1983 Kettman JR, Smith RG, Uhr JW, Vitetta ES, Sheehan R, Ligler FS, Frenkel EP. Quantitative monitoring of lymphoid malignancies. Application and findings in chronic lymphocytic leukemia. Blood Cells. 9: 21-33. PMID 6407550  1
1983 Krolick KA, Uhr JW, Vitetta ES. Preparation and application of antibodies coupled to the A chain of ricin. Methods in Enzymology. 93: 333-8. PMID 6346013  1
1983 Weiss L, Morecki S, Vitetta ES, Slavin S. Suppression and elimination of BCL1 leukemia by allogeneic bone marrow transplantation. Journal of Immunology (Baltimore, Md. : 1950). 130: 2452-5. PMID 6339628  1
1983 Waldschmidt TJ, Borel Y, Vitetta ES. The use of haptenated immunoglobulins to induce B cell tolerance in vitro. The roles of hapten density and the Fc portion of the immunoglobulin carrier. Journal of Immunology (Baltimore, Md. : 1950). 131: 2204-9. PMID 6226736  1
1983 May RD, Slavin S, Vitetta ES. A partial characterization of suppressor cells in the spleens of mice conditioned with fractionated total lymphoid irradiation (TLI). Journal of Immunology (Baltimore, Md. : 1950). 131: 1108-14. PMID 6224848  1
1983 Vitetta ES, Krolick KA, Miyama-Inaba M, Cushley W, Uhr JW. Immunotoxins: a new approach to cancer therapy. Science (New York, N.Y.). 219: 644-50. PMID 6218613 DOI: 10.1126/Science.6218613  1
1983 Yuan D, Vitetta ES. Structural studies of cell surface and secreted IgG in LPS-stimulated murine B cells. Molecular Immunology. 20: 367-75. PMID 6191206 DOI: 10.1016/0161-5890(83)90018-4  1
1982 Soloski MJ, McIntyre KR, Uhr JW, Vitetta ES. Primary structural analysis of the Tla region gene products, QA-2 and TL. Molecular Immunology. 19: 1193-7. PMID 7144758 DOI: 10.1016/0161-5890(82)90330-3  1
1982 Soloski MJ, Uhr JW, Vitetta ES. Primary structural studies of the Qa-2 alloantigen: implications for the evolution of the MHC. Nature. 296: 759-61. PMID 7070515 DOI: 10.1038/296759a0  1
1982 McIntyre KR, Hämmerling U, Uhr JW, Vitetta ES. Structural analysis of thymus-leukemia (TL) antigens in the mouse. Journal of Immunology (Baltimore, Md. : 1950). 128: 1712-7. PMID 7061847  1
1982 Vitetta ES, Krolick KA, Uhr JW. Neoplastic B cells as targets for antibody-ricin A chain immunotoxins. Immunological Reviews. 62: 159-83. PMID 7042537 DOI: 10.1111/J.1600-065X.1982.Tb00393.X  1
1982 Isakson PC, Puré E, Vitetta ES, Krammer PH. T cell-derived B cell differentiation factor(s). Effect on the isotype switch of murine B cells. The Journal of Experimental Medicine. 155: 734-48. PMID 7038025 DOI: 10.1084/Jem.155.3.734  1
1982 Krolick KA, Uhr JW, Vitetta ES. Selective killing of leukaemia cells by antibody-toxin conjugates: implications for autologous bone marrow transplantation. Nature. 295: 604-5. PMID 7035973 DOI: 10.1038/295604a0  1
1982 Vitetta ES. Immunoglobulin receptors reevaluated. Annals of the New York Academy of Sciences. 399: 255-64. PMID 6984608  1
1982 Pure E, Isakson PC, Paetkau V, Caplan B, Vitetta ES, Krammer PH. Interleukin-2 does not induce murine B cells to secrete Ig. Journal of Immunology (Baltimore, Md. : 1950). 129: 2420-5. PMID 6982922  0.56
1982 Krolick KA, Uhr JW, Slavin S, Vitetta ES. In vivo therapy of a murine B cell tumor (BCL1) using antibody-ricin A chain immunotoxins. The Journal of Experimental Medicine. 155: 1797-809. PMID 6804591 DOI: 10.1084/Jem.155.6.1797  1
1982 Yuan D, Hendler FJ, Vitetta ES. Characterization of a monoclonal antibody reactive with a subset of human breast tumors. Journal of the National Cancer Institute. 68: 719-28. PMID 6279951 DOI: 10.1093/jnci/68.5.719  1
1981 Hendler FJ, Yuan D, Vitetta ES. Characterization of a monoclonal antibody to human breast cancer cells Transactions of the Association of American Physicians. 94: 217-224. PMID 7344221  1
1981 Soloski MJ, Vitetta ES, Flaherty L, Uhr JW. Biochemical analysis of an MHC-linked hematopoietic cell surface antigen, Qa-2. Journal of Supramolecular Structure and Cellular Biochemistry. 16: 167-77. PMID 7299842 DOI: 10.1002/jsscb.1981.380160207  1
1981 Muirhead MJ, Isakson PC, Krolick KA, Uhr JW, Vitetta ES. BCL1, a murine model of prolymphocytic leukemia. I. Effect of splenectomy on growth kinetics and organ distribution. The American Journal of Pathology. 105: 295-305. PMID 7032308  1
1981 McGuire KL, Vitetta ES. κ/λ shifts do not occur during maturation of murine B cells Journal of Immunology. 127: 1670-1673. PMID 7024412  1
1981 Muirhead MJ, Holbert JM, Uhr JW, Vitetta ES. BCL1, a murine model of prolymphocytic leukemia. II. Morphology and ultrastructure. The American Journal of Pathology. 105: 306-15. PMID 6976124  1
1981 Yuan D, Uhr JW, Vitetta ES. Detection of unique peptides derived from the μ chains of cell surface but not secreted IgM Molecular Immunology. 18: 467-471. PMID 6796822 DOI: 10.1016/0161-5890(81)90123-1  1
1981 Soloski MJ, Uhr JW, Flaherty L, Vitetta ES. Qa-2, H-2K, and H-2D alloantigens evolved from a common ancestral gene. The Journal of Experimental Medicine. 153: 1080-93. PMID 6788884  1
1981 Isakson PC, Pure E, Uhr JW, Vitetta ES. Induction of proliferation and differentiation of neoplastic B cells by anti-immunoglobulin and T-cell factors Proceedings of the National Academy of Sciences of the United States of America. 78: 2507-2511. PMID 6787608 DOI: 10.1073/Pnas.78.4.2507  1
1981 Forman J, Ciavarra R, Vitetta ES. Cytotoxic T cells specific for antigens expressed on surface immunoglobulin-positive cells Journal of Experimental Medicine. 154: 1357-1368. PMID 6170717 DOI: 10.1084/JEM.154.5.1357  1
1981 Kanowith-Klein S, Vitetta ES, Ashman RF. The isotype cycle: successive changes in surface immunoglobulin classes expressed by the antigen-binding B-cell population during the primary in vivo response. Cellular Immunology. 62: 377-84. PMID 6169454 DOI: 10.1016/0008-8749(81)90338-5  1
1981 Lafrenz D, Strober S, Vitetta E. The relationship between surface immunoglobulin isotype and the immune function of murine B lymphocytes. V. High affinity secondary antibody responses are transferred by both IgD-positive and IgD-negative memory B cells Journal of Immunology. 127: 867-872. PMID 6167629  1
1981 Krolick KA, Yuan D, Vitetta ES. Specific killing of a human breast carcinoma cell line by a monoclonal antibody coupled to the A-chain of ricin Cancer Immunology Immunotherapy. 12: 39-41. DOI: 10.1007/BF00200310  1
1980 Uhr JW, Vitetta ES. Function of surface immunoglobulin on murine B cells Progress in Clinical and Biological Research. 42: 46-68. PMID 6994118  1
1980 Pure E, Vitetta E. Induction of murine B cell proliferation by insolubilized anti-immunoglobulins Journal of Immunology. 125: 1240-1242. PMID 6967895  1
1980 Vitetta E, Puré E, Isakson P, Buck L, Uhr J. The activation of murine B cells: the role of surface immunoglobulins Immunological Reviews. 52: 211-231. PMID 6790419 DOI: 10.1111/J.1600-065X.1980.Tb00336.X  1
1980 Yuan D, Uhr JW, Vitetta ES. A peptide difference between the μ-chains from cell-associated and secreted IgM of the BCL1 tumor Journal of Immunology. 125: 40-46. PMID 6770002  1
1980 Vitetta E, Krolick K. Allelic exclusion of IgD allotypes on murine B cells Journal of Immunology. 124: 2988-2990. PMID 6768803  1
1980 Pure E, Vitetta ES. The murine B cell response to TNP-polyacrylamide beads: The relationship between the epitope density of the antigen and the requirements for T cell help and surface IgD Journal of Immunology. 125: 420-427. PMID 6155404  1
1979 Hamilton MS, Beer AE, May RD, Vitetta ES. The influence of immunization of female mice with F9 teratocarcinoma cells on their reproductive performance Transplantation Proceedings. 11: 1069-1072. PMID 572107  1
1979 Baechtel FS, Prager MD, Vitetta ES. Identification of autoanti-Thy-1 antibody in the sera of BALB/c mice immune to P1798 lymphoma European Journal of Immunology. 9: 450-454. PMID 499326  1
1979 Cook RG, Vitetta ES, Uhr JW, Capra JD. Structural studies on the murine Ia alloantigens. V. Evidence that the structural gene for the I-E/C beta polypeptide is encoded within the I-A subregion. The Journal of Experimental Medicine. 149: 981-6. PMID 429967 DOI: 10.1084/JEM.149.4.981  1
1979 Zan-Bar I, Strober S, Vitetta ES. The relationship between surface immunoglobulin isotype and immune function of murine B lymphocytes. IV. Role of IgD-bearing cells in the propagation of immunologic memory Journal of Immunology. 123: 925-930. PMID 313424  1
1979 Buck LB, Yuan D, Vitetta ES. A dichotomy between the expression of IgD on B cells and its requirement for triggering such cells with two T-independent antigens. The Journal of Experimental Medicine. 149: 987-92. PMID 311818 DOI: 10.1084/Jem.149.4.987  1
1979 Uhr JW, Capra JD, Vitetta ES, Cook RG. Organization of the immune response genes. Science (New York, N.Y.). 206: 292-7. PMID 113876 DOI: 10.1126/SCIENCE.113876  1
1979 Vitetta ES, Cook RG. Surface expression and synthesis of I-A and I-E/C encoded molecules by B lymphocytes and Ig-secreting cells. Journal of Immunology (Baltimore, Md. : 1950). 122: 2122-30. PMID 109526  1
1978 Michaelson J, Flaherty L, Vitetta E, Boyse EA. Biochemical demonstration- of anti-Qa activity in an H-2.28 public specificity antiserum. Immunogenetics. 7: 265-9. PMID 21302081 DOI: 10.1007/BF01844014  1
1978 Vitetta ES, Hart DA, Forman J. Relationship between trinitrophenol and H-2 antigens on trinitrophenyl-modified spleen cells. III. Quantitative aspects of trinitrophenol binding on cells treated with trinitrobenzene sulfonic acid Journal of Immunology. 121: 997-1001. PMID 690447  1
1978 Schwartz BD, Vitetta ES, Cullen SE. Labeling characteristics and separation of Ia antigen subunits. Journal of Immunology (Baltimore, Md. : 1950). 120: 671-5. PMID 621402  1
1978 Yuan D, Vitetta ES. Cell surface immunoglobulin. XXI. Appearance of IgD on murine lymphocytes during differentiation Journal of Immunology. 120: 353-356. PMID 340585  1
1978 Uhr JW, Vitetta ES. Differentiation of bone marrow-derived lymphocytes National Cancer Institute Monograph. 295-300. PMID 311890  1
1978 Cohen P, Ziff M, Vitetta ES. Characterization of a B cell defect in the NZB mouse manifested by an increased ratio of surface IgM to IgD Journal of Immunology. 121: 973-977. PMID 308525  1
1978 Vitetta ES, Capra JD. The protein products of the murine 17th chromosome: genetics and structure Advances in Immunology. 26: 147-193. PMID 99995  1
1978 Forman J, Vitetta ES. Relationship between trinitrophenol and H-2 antigens on trinitrophenyl-modified spleen cells. IV. Correlation between the loss of cell surface trinitrophenyl-H-2 molecules and functional activity of derivatized cells in an anti-TNP-CML assay Journal of Immunology. 121: 1002-1006. PMID 80421  1
1977 Ligler F, Vitetta ES, Uhr JW. Cell surface immunoglobulin. XXII. Reappearance of surface IgM and IgD on murine splenocytes after removal by capping Journal of Immunology. 119: 1545-1546. PMID 894051  1
1977 Michaelson J, Flaherty L, Vitetta E, Poulik MD. Molecular similarities between the Qa-2 alloantigen and other gene products of the 17th chromosome of the mouse. The Journal of Experimental Medicine. 145: 1066-70. PMID 858995  1
1977 Vitetta ES, Cook R, Artzt K, Poulik MD, Uhr JW. Further structural studies on the F9 (T/t) antigen(s). European Journal of Immunology. 7: 826-9. PMID 590322 DOI: 10.1002/eji.1830071116  1
1977 Zan Bar I, Vitetta ES, Strober S. The relationship between surface immunoglobulin isotype and immune function of murine B lymphocytes. II. Surface immunoglobulin isotopes on unprimed B cells in the spleen Journal of Experimental Medicine. 145: 1206-1215. PMID 323403 DOI: 10.1084/Jem.145.5.1206  1
1977 Zan Bar I, Strober S, Vitetta ES. The relationship between surface immunoglobulin isotype and immune function of murine B lymphocytes. I. Surface immunoglobulin isotypes on primed B cells in the spleen Journal of Experimental Medicine. 145: 1188-1205. PMID 323402 DOI: 10.1084/jem.145.5.1188  1
1977 Yuan D, Vitetta ES, Kettman JR. Cell surface immunoglobulin. XX. Antibody responsiveness of subpopulations of B lymphocytes bearing different isotypes Journal of Experimental Medicine. 145: 1421-1435. PMID 301171  1
1977 Vitetta ES, Uhr JW. IgD and B cell differentiation Immunological Reviews. 37: 50-88. PMID 73499 DOI: 10.1111/J.1600-065X.1977.Tb00245.X  1
1977 Forman J, Vitetta ES, Hart DA. Relationship between trinitrophenyl and H2 antigens on trinitrophenyl modified spleen cells. II Journal of Immunology. 118: 803-808. PMID 66273  1
1977 Forman J, Vitetta ES, Hart DA, Klein J. Relationship between trinitrophenyl and H2 antigens on trinitrophenyl modified spleen cells. I. H2 antigens on cells treated with trinitrobenzene sulfonic acid are derivatized Journal of Immunology. 118: 797-802. PMID 66272  1
1977 Yuan D, Vitetta ES, Schachner M. Partial characterization of nervous system specific cell surface antigen(s) NS-2 Journal of Immunology. 118: 551-557. PMID 65427  1
1977 Tung JS, Michaelson J, Sato H, Vitetta ES, Boyse EA. Properties of the Lyb-2 molecule Immunogenetics. 5: 485-488. DOI: 10.1007/BF01570509  1
1977 Cook R, Vitetta ES, Capra JD, Uhr JW. The partial amino acid sequence of a murine Ia molecule - Lack of homology between murine I-Cγ d and human P29 Immunogenetics. 5: 437-443. DOI: 10.1007/BF01570502  1
1977 Cambier J, Kettman JR, Vitetta ES, Uhr JW. Tolerance susceptibility of murine B cells response to thymus dependent and independent carriers of the hapten, 2,4,6 trinitrophenyl Federation Proceedings. 36: No. 5471.  1
1976 Vitetta ES, Uhr JW. Cell surface immunoglobulin. XIX. Susceptibility of IgD and IgM on murine splenocytes to cleavage by papain Journal of Immunology. 117: I. PMID 1087317  1
1976 Vitetta ES, Forman J, Kettman JR. Cell surface immunoglobulin. XVIII. Functional differences of B lymphocytes bearing different surface immunoglobulin isotypes Journal of Experimental Medicine. 143: 1055-1066. PMID 1083417  1
1976 Capra JD, Vitetta ES, Klapper DG, Uhr JW, Klein J. Structural studies on protein products of murine chromosome 17: Partial amino acid sequence of an H-2K(b) molecule Proceedings of the National Academy of Sciences of the United States of America. 73: 3661-3665. PMID 1068479 DOI: 10.1073/pnas.73.10.3661  1
1976 Vitetta ES, Capra JD, Klapper DG, Klein J, Uhr JW. The partial amino acid sequence of an H-2K molecule Proceedings of the National Academy of Sciences of the United States of America. 73: 905-909. PMID 1062803 DOI: 10.1073/pnas.73.3.905  1
1976 Vitetta ES, Uhr JW. Cell surface immunoglobulin. XV. The presence of IgM and an IgD like molecule on the same cell in murine lymphoid tissue European Journal of Immunology. 6: 140-143. PMID 964297  1
1976 Uhr JW, Vitetta ES, Klein J, Poulik MD, Klapper DG, Capra JD. Structural studies of H 2 and TL alloantigens Cold Spring Harbor Symposia On Quantitative Biology. 41: 363-368. PMID 70314 DOI: 10.1101/SQB.1977.041.01.043  1
1976 Vitetta ES, Poulik MD, Klein J, Uhr JW. Beta 2 microglobulin is selectively associated with H 2 and TL alloantigens on murine lymphoid cells Journal of Experimental Medicine. 144: 179-192. PMID 58956 DOI: 10.1084/JEM.144.1.179  1
1976 Geib R, Poulik MD, Vitetta ES. Relationship between β2 microglobulin and cell surface alloantigens of the mouse Journal of Immunology. 117.  1
1975 Vitetta ES, Uhr JW. Synthesis of surface H2 alloantigens in murine splenocytes Journal of Immunology. 115: 374-381. PMID 1151063  1
1975 Vitetta ES, Uhr JW. Immunoglobulins and alloantigens on the surface of lymphoid cells Bba - Reviews On Biomembranes. 415: 253-271. PMID 1096960 DOI: 10.1016/0304-4157(75)90004-0  1
1975 Vitetta ES, Uhr JW. Immunoglobulin-receptors revisited Science. 189: 964-969. PMID 1083069 DOI: 10.1126/Science.1083069  1
1975 Vitetta ES, Artzt K, Bennett D, Boyse EA, Jacob F. Structural similarities between a product of the T/t-locus isolated from sperm and teratoma cells, and H-2 antigens isolated from splenocytes. Proceedings of the National Academy of Sciences of the United States of America. 72: 3215-9. PMID 1059107 DOI: 10.1073/pnas.72.8.3215  1
1975 Capra JD, Vitetta ES, Klein J. Studies on the murine Ss protein. I. Purification, molecular weight, and subunit structure Journal of Experimental Medicine. 142: 664-672. PMID 809530  1
1975 Goodman SA, Vitetta ES, Melcher U, Uhr JW. Cell surface immunoglobulin. XIII. Distribution of IgM and IgD like molecules on small and large cells of mouse spleen Journal of Immunology. 114: 1646-1648. PMID 804522  1
1975 Tung JS, Fleissner E, Vitetta ES, Boyse EA. Expression of murine leukemia virus envelope glycoprotein gp69/71 on mouse thymocytes. Evidence for two structural variants distinguished by presence vs absence of G(ix) antigen Journal of Experimental Medicine. 142: 518-523. PMID 167098  1
1975 Tung JS, Vitetta ES, Fleissner E, Boyse EA. Biochemical evidence linking the G(IX) thymocyte surface antigen to the gp69/71 envelope glycoprotein of murine leukemia virus Journal of Experimental Medicine. 141: 198-205. PMID 163885  1
1975 Forman J, Vitetta ES. Absence of H 2 antigens capable of reacting with cytotoxic T cells on a teratoma line expressing a T/t locus antigen Proceedings of the National Academy of Sciences of the United States of America. 72: 3661-3665. PMID 52873  1
1975 Strayer DS, Vitetta ES, Kohler H. Anti receptor antibody. I. Isolation and characterization of the immunoglobulin receptor for phosphorylcholine Journal of Immunology. 114. PMID 46887  1
1975 Vitetta ES, Uhr JW, Boyse EA. Association of a β2 microglobulin like subunit with H-2 and TL alloantigens on murine thymocytes Journal of Immunology. 114: 252-254. PMID 46243  1
1974 Vitetta ES, Uhr JW. Dynamics of immunoglobulin and alloantigens on lymphocytes Res Journal of the Reticuloendothelial Society. 15: 247-253. PMID 4838133  1
1974 Vitetta ES, Uhr JW. Cell surface immunoglobulin. IX. A new method for the study of synthesis, intracellular transport, and exteriorization in murine splenocytes Journal of Experimental Medicine. 139: 1599-1620. PMID 4829935 DOI: 10.1084/Jem.139.6.1599  1
1974 Uhr JW, Vitetta ES. Cell surface immunoglobulin. VIII. Synthesis, secretion, and cell surface expression of immunoglobulin in murine thoracic duct lymphocytes Journal of Experimental Medicine. 139: 1013-1018. PMID 4816299 DOI: 10.1084/Jem.139.4.1013  1
1974 Uhr JW, Vitetta ES, Melcher UK. Regulation of cell surface immunoglobulin and alloantigens on lymphocytes Society of General Physiologists Series. 29: 133-141. PMID 4610761  1
1974 Vitetta ES, Uhr JW, Boyse EA. Metabolism of H2 and Thy 1 (theta) alloantigens in murine thymocytes European Journal of Immunology. 4: 276-282. PMID 4546863  1
1974 Vitetta ES, Klein J, Uhr JW. Partial characterization of Ia antigens from murine lymphoid cells Immunogenetics. 1: 82-90. DOI: 10.1007/BF01564048  1
1973 Uhr JW, Vitetta ES. Synthesis, biochemistry and dynamics of cell surface immunoglobulin on lymphocytes Federation Proceedings. 32: 35-40. PMID 4567776  1
1973 Vitetta ES, Boyse EA, Uhr JW. Isolation and characterization of a molecular complex containing Thy 1 antigen from the surface of murine thymocytes and T cells European Journal of Immunology. 3: 446-453. PMID 4543319 DOI: 10.1002/Eji.1830030714  1
1973 Vitetta ES, Uhr JW. Synthesis, transport, dynamics and fate of cell surface Ig and alloantigens in murine lymphocytes Transplant Rev.. 14: 50-75. PMID 4542308 DOI: 10.1111/J.1600-065X.1973.Tb00102.X  1
1973 Vitetta ES, Uhr JW, Boyse EA. Immunoglobulin synthesis and secretion by cells in the mouse thymus that do not bear theta antigen Proceedings of the National Academy of Sciences of the United States of America. 70: 834-838. PMID 4514995 DOI: 10.1073/Pnas.70.3.834  1
1973 Wernet D, Vitetta ES, Uhr JW, Boyse EA. Synthesis, intracellular distribution, and secretion of immunoglobulin and H 2 antigen in murine splenocytes Journal of Experimental Medicine. 138: 847-857. PMID 4200648  1
1972 Vitetta ES, Uhr JW. Cell surface immunoglobulin. V. Release from murine splenic lymphocytes Journal of Experimental Medicine. 136: 676-696. PMID 5056670  1
1972 Vitetta ES, Uhr JW. Release of cell surface immunoglobulin by mouse splenic lymphocytes Journal of Immunology. 108: 577-579. PMID 5049100  1
1972 Vitetta E, Uhr JW, Boyse EA. Isolation and characterization of H-2 and TL alloantigens from the surface of mouse lymphocytes Cellular Immunology. 4: 187-191. PMID 5028167 DOI: 10.1016/0008-8749(72)90019-6  1
1971 Vitetta ES, Baur S, Uhr JW. Cell surface immunoglobulin. II. Isolation and characterization of immunoglobulin from mouse splenic lymphocytes Journal of Experimental Medicine. 134: 242-264. PMID 4104295  1
1969 Vitetta ES, Guttman HN. Salt—Isoelectric—Density Gradient (SID) Purification of Rabbit IgG Proceedings of the Society For Experimental Biology and Medicine. 130: 577-581. PMID 4179542 DOI: 10.3181/00379727-130-33611  1
1968 Vitetta ES, Guttman HN. Kinetics of the immune response of rabbits to lower trypanosomatidae antigens Journal of General Microbiology. 50: 67-76. PMID 5635523  1
1967 Guttman HN, Vitetta ES. Endosymbiosis: infection and cure Yale Journal of Biology and Medicine. 40: 183-191. PMID 4869095  1
Show low-probability matches.